{
    "abstract": "Background: The adjuvanted recombinant zoster vaccine (RZV) received its first marketing authorization in October 2017, for prevention of herpes zoster in individuals aged \u226550 years. Methods: We summarized safety information, following RZV administration, received by GSK via spontaneous adverse event (AE) reports submitted by healthcare providers, vaccine recipients and other reporters. Observed-to-expected (O/E) analyses were performed for selected outcomes: reports of death, Guillain\u2013Barr\u00e9 syndrome and Bell's palsy. Standard case definitions were used to assess individual case reports. Data mining, using proportional reporting ratio and time-to-onset signal detection methods, was employed to identify RZV-AE pairs with disproportionate reporting or unexpected time-to-onset distribution. Results: Between October 13, 2017 and February 10, 2019, an estimated 9.3 million doses were distributed and GSK received 15,638 spontaneous AE reports involving RZV. Most reports were classified as non-serious (95.3%) and originated from the United States (81.7%), where the majority of doses were distributed. Among reports with age or sex reported, individuals were mainly 50\u201369-year-olds (62.1%) and female (66.7%). Of all reports, 3,579 (22.9%) described vaccination errors, of which 82.7% were without associated symptoms. Of all vaccination error reports, most described errors of vaccine preparation and reconstitution (29.7%), inappropriate schedule or incomplete course of administration (26.7%), incorrect route of administration (16.4%), and storage errors (12.9%). The most commonly reported symptoms were consistent with the known RZV reactogenicity profile observed in clinical trials, including injection site reactions, pyrexia, chills, fatigue, headache. O/E analyses for selected outcomes and data mining analyses for all reported AEs did not identify any unexpected patterns. Conclusions: Review of the initial data from the post-marketing safety surveillance showed that the safety profile of RZV is consistent with that previously observed in pre-licensure clinical trials. Other studies are ongoing and planned, to continue generating real-world safety data and further characterize RZV.",
    "author_highlights": [
        {
            "endOffset": 22450,
            "sentence": "The adjuvanted recombinant zoster vaccine (RZV) is licensed for herpes zoster prevention in \u226550-year-olds.",
            "startOffset": 22344
        },
        {
            "endOffset": 22540,
            "sentence": "Post-licensure spontaneous safety reports received up to February 10, 2019 were reviewed.",
            "startOffset": 22451
        },
        {
            "endOffset": 22641,
            "sentence": "Of 15,638 reports, most were non-serious, from US, and associated with known vaccine reactogenicity.",
            "startOffset": 22541
        },
        {
            "endOffset": 22697,
            "sentence": "No unexpected reporting patterns were detected overall.",
            "startOffset": 22642
        },
        {
            "endOffset": 22774,
            "sentence": "The RZV safety profile was consistent with that observed in clinical trials.",
            "startOffset": 22698
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Jeffrey I.",
                    "initial": "J.I.",
                    "last": "Cohen"
                }
            ],
            "doi": "10.1056/NEJMcp1302674",
            "firstpage": "255",
            "issn": "00284793",
            "lastpage": "263",
            "pmid": "23863052",
            "pub_year": 2013,
            "title": "Herpes Zoster",
            "volume": "369"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Kosuke",
                    "initial": "K.",
                    "last": "Kawai"
                },
                {
                    "first": "Berhanu G.",
                    "initial": "B.G.",
                    "last": "Gebremeskel"
                },
                {
                    "first": "Camilo J.",
                    "initial": "C.J.",
                    "last": "Acosta"
                }
            ],
            "doi": "10.1136/bmjopen-2014-004833",
            "issn": "20446055",
            "pmid": "24916088",
            "pub_year": 2014,
            "title": "Systematic review of incidence and complications of herpes zoster: Towards a global perspective",
            "volume": "4"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Barbara P.",
                    "initial": "B.P.",
                    "last": "Yawn"
                },
                {
                    "first": "Don",
                    "initial": "D.",
                    "last": "Gilden"
                }
            ],
            "doi": "10.1212/WNL.0b013e3182a3516e",
            "firstpage": "928",
            "issn": "00283878",
            "lastpage": "930",
            "pmid": "23999562",
            "pub_year": 2013,
            "title": "Global perspectives",
            "volume": "81"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Barbara P.",
                    "initial": "B.P.",
                    "last": "Yawn"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Saddier"
                },
                {
                    "first": "Peter C.",
                    "initial": "P.C.",
                    "last": "Wollan"
                },
                {
                    "first": "Jennifer L.",
                    "initial": "J.L.",
                    "last": "St. Sauver"
                },
                {
                    "first": "Marge J.",
                    "initial": "M.J.",
                    "last": "Kurland"
                },
                {
                    "first": "Lina S.",
                    "initial": "L.S.",
                    "last": "Sy"
                }
            ],
            "doi": "10.4065/82.11.1341",
            "firstpage": "1341",
            "issn": "00256196",
            "lastpage": "1349",
            "pub_year": 2007,
            "title": "A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction",
            "volume": "82"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Johnson"
                },
                {
                    "first": "Andrew S.C.",
                    "initial": "A.S.C.",
                    "last": "Rice"
                }
            ],
            "doi": "10.1056/NEJMcp1403062",
            "firstpage": "1526",
            "issn": "00284793",
            "lastpage": "1533",
            "pmid": "25317872",
            "pub_year": 2014,
            "title": "Postherpetic neuralgia",
            "volume": "371"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Thomas J.",
                    "initial": "T.J.",
                    "last": "Liesegang"
                }
            ],
            "doi": "10.1016/j.ophtha.2007.10.009",
            "firstpage": "S3",
            "issn": "01616420",
            "lastpage": "S12",
            "pmid": "18243930",
            "pub_year": 2008,
            "title": "Herpes Zoster Ophthalmicus. Natural History, Risk Factors, Clinical Presentation, and Morbidity",
            "volume": "115"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Barbara P.",
                    "initial": "B.P.",
                    "last": "Yawn"
                },
                {
                    "first": "Peter C.",
                    "initial": "P.C.",
                    "last": "Wollan"
                },
                {
                    "first": "Jennifer L.",
                    "initial": "J.L.",
                    "last": "St. Sauver"
                },
                {
                    "first": "Linda C.",
                    "initial": "L.C.",
                    "last": "Butterfield"
                }
            ],
            "doi": "10.1016/j.mayocp.2013.03.014",
            "firstpage": "562",
            "issn": "00256196",
            "lastpage": "570",
            "pub_year": 2013,
            "title": "Herpes zoster eye complications: Rates and trends",
            "volume": "88"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Kimberly D.",
                    "initial": "K.D.",
                    "last": "Tran"
                },
                {
                    "first": "Michelle M.",
                    "initial": "M.M.",
                    "last": "Falcone"
                },
                {
                    "first": "Daniel S.",
                    "initial": "D.S.",
                    "last": "Choi"
                },
                {
                    "first": "Raquel",
                    "initial": "R.",
                    "last": "Goldhardt"
                },
                {
                    "first": "Carol L.",
                    "initial": "C.L.",
                    "last": "Karp"
                },
                {
                    "first": "Janet L.",
                    "initial": "J.L.",
                    "last": "Davis"
                },
                {
                    "first": "Anat",
                    "initial": "A.",
                    "last": "Galor"
                }
            ],
            "doi": "10.1016/j.ophtha.2016.03.005",
            "firstpage": "1469",
            "issn": "01616420",
            "lastpage": "1475",
            "pmid": "27067924",
            "pub_year": 2016,
            "title": "Epidemiology of Herpes Zoster Ophthalmicus Recurrence and Chronicity",
            "volume": "123"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Johnson"
                },
                {
                    "first": "Didier",
                    "initial": "D.",
                    "last": "Bouhassira"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Kassianos"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Lepl\u00e8ge"
                },
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Weinke"
                }
            ],
            "doi": "10.1186/1741-7015-8-37",
            "issn": "17417015",
            "pmid": "20565946",
            "pub_year": 2010,
            "title": "The impact of herpes zoster and post-herpetic neuralgia on quality-of-life",
            "volume": "8"
        },
        "b0050": {
            "authors": [
                {
                    "first": "A. L.",
                    "initial": "A.L.",
                    "last": "Cunningham"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Lal"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Kovac"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Hwang"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "D\u00edez-Domingo"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Godeaux"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "McElhaney"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Vanden Abeele"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Watanabe"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Ahonen"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Athan"
                },
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Barba-Gomez"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Campora"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "De Looze"
                },
                {
                    "first": "H. J.",
                    "initial": "H.J.",
                    "last": "Downey"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Ghesquiere"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Gorfinkel"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Korhonen"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Leung"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "McNeil"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Oostvogels"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Rombo"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Smetana"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Weckx"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Yeo"
                },
                {
                    "first": "T. C.",
                    "initial": "T.C.",
                    "last": "Heineman"
                }
            ],
            "doi": "10.1056/NEJMoa1603800",
            "firstpage": "1019",
            "issn": "00284793",
            "lastpage": "1032",
            "pmid": "27626517",
            "pub_year": 2016,
            "title": "Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older",
            "volume": "375"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Himal",
                    "initial": "H.",
                    "last": "Lal"
                },
                {
                    "first": "Anthony L.",
                    "initial": "A.L.",
                    "last": "Cunningham"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Godeaux"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Diez-Domingo"
                },
                {
                    "first": "Shinn Jang",
                    "initial": "S.J.",
                    "last": "Hwang"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Janet E.",
                    "initial": "J.E.",
                    "last": "McElhaney"
                },
                {
                    "first": "Airi",
                    "initial": "A.",
                    "last": "Poder"
                },
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Daisuke",
                    "initial": "D.",
                    "last": "Watanabe"
                },
                {
                    "first": "Lily",
                    "initial": "L.",
                    "last": "Weckx"
                },
                {
                    "first": "Toufik",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": "Thomas C.",
                    "initial": "T.C.",
                    "last": "Heineman"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1056/NEJMoa1501184",
            "firstpage": "2087",
            "issn": "00284793",
            "lastpage": "2096",
            "pmid": "25916341",
            "pub_year": 2015,
            "title": "Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults",
            "volume": "372"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "L\u00f3pez-Fauqued"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Campora"
                },
                {
                    "first": "Fr\u00e9d\u00e9rique",
                    "initial": "F.",
                    "last": "Delannois"
                },
                {
                    "first": "Mohamed",
                    "initial": "M.",
                    "last": "El Idrissi"
                },
                {
                    "first": "Lidia",
                    "initial": "L.",
                    "last": "Oostvogels"
                },
                {
                    "first": "Ferdinandus J.",
                    "initial": "F.J.",
                    "last": "De Looze"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Diez-Domingo"
                },
                {
                    "first": "Thomas C.",
                    "initial": "T.C.",
                    "last": "Heineman"
                },
                {
                    "first": "Himal",
                    "initial": "H.",
                    "last": "Lal"
                },
                {
                    "first": "Janet E.",
                    "initial": "J.E.",
                    "last": "McElhaney"
                },
                {
                    "first": "Shelly A.",
                    "initial": "S.A.",
                    "last": "McNeil"
                },
                {
                    "first": "Wilfred",
                    "initial": "W.",
                    "last": "Yeo"
                },
                {
                    "first": "Fernanda",
                    "initial": "F.",
                    "last": "Tavares-Da-Silva"
                },
                {
                    "first": "Anitta",
                    "initial": "A.",
                    "last": "Ahonen"
                },
                {
                    "first": "Thiago Junquera",
                    "initial": "T.J.",
                    "last": "Avelino-Silva"
                },
                {
                    "first": "Jose Fernando",
                    "initial": "J.F.",
                    "last": "Barba-Gomez"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Berglund"
                },
                {
                    "first": "Carlos Brotons",
                    "initial": "C.B.",
                    "last": "Cuixart"
                },
                {
                    "first": "Covadonga",
                    "initial": "C.",
                    "last": "Caso"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "Won Suk",
                    "initial": "W.S.",
                    "last": "Choi"
                },
                {
                    "first": "Anthony L.",
                    "initial": "A.L.",
                    "last": "Cunningham"
                },
                {
                    "first": "Maria Guiseppina",
                    "initial": "M.G.",
                    "last": "Desole"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Eizenberg"
                },
                {
                    "first": "Meral",
                    "initial": "M.",
                    "last": "Esen"
                },
                {
                    "first": "Emmanuelle",
                    "initial": "E.",
                    "last": "Espi\u00e9"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Gervais"
                },
                {
                    "first": "Wayne",
                    "initial": "W.",
                    "last": "Ghesquiere"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Godeaux"
                },
                {
                    "first": "Iris",
                    "initial": "I.",
                    "last": "Gorfinkel"
                },
                {
                    "first": "David Shu Cheong",
                    "initial": "D.S.C.",
                    "last": "Hui"
                },
                {
                    "first": "Shinn Jang",
                    "initial": "S.J.",
                    "last": "Hwang"
                },
                {
                    "first": "Tiina",
                    "initial": "T.",
                    "last": "Korhonen"
                },
                {
                    "first": "Martina",
                    "initial": "M.",
                    "last": "Kovac"
                },
                {
                    "first": "Edouard",
                    "initial": "E.",
                    "last": "Ledent"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Leung"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Silvia Narejos",
                    "initial": "S.N.",
                    "last": "Perez"
                },
                {
                    "first": "Jose Luiz",
                    "initial": "J.L.",
                    "last": "Neto"
                },
                {
                    "first": "Karlis",
                    "initial": "K.",
                    "last": "Pauksens"
                },
                {
                    "first": "Airi",
                    "initial": "A.",
                    "last": "Poder"
                },
                {
                    "first": "Maria Luisa Rodriguez",
                    "initial": "M.L.R.",
                    "last": "de la Pinta"
                },
                {
                    "first": "Lars",
                    "initial": "L.",
                    "last": "Rombo"
                },
                {
                    "first": "Tino F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Smetana"
                },
                {
                    "first": "Tommaso",
                    "initial": "T.",
                    "last": "Staniscia"
                },
                {
                    "first": "Juan Carlos",
                    "initial": "J.C.",
                    "last": "Tinoco"
                },
                {
                    "first": "Azhar",
                    "initial": "A.",
                    "last": "Toma"
                },
                {
                    "first": "Ilse",
                    "initial": "I.",
                    "last": "Vastiau"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Volpi"
                },
                {
                    "first": "Daisuke",
                    "initial": "D.",
                    "last": "Watanabe"
                },
                {
                    "first": "Lily Yin",
                    "initial": "L.Y.",
                    "last": "Weckx"
                },
                {
                    "first": "Toufik",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2019.03.043",
            "firstpage": "2482",
            "issn": "0264410X",
            "lastpage": "2493",
            "pmid": "30935742",
            "pub_year": 2019,
            "title": "Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials",
            "volume": "37"
        },
        "b0065": null,
        "b0070": null,
        "b0075": null,
        "b0080": {
            "authors": [
                {
                    "first": "Lionel",
                    "initial": "L.",
                    "last": "Van Holle"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Bauchau"
                }
            ],
            "doi": "10.1007/s40264-014-0237-9",
            "firstpage": "1047",
            "issn": "01145916",
            "lastpage": "1057",
            "pmid": "25395263",
            "pub_year": 2014,
            "title": "Use of Logistic Regression to Combine Two Causality Criteria for Signal Detection in Vaccine Spontaneous Report Data",
            "volume": "37"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Lionel",
                    "initial": "L.",
                    "last": "Van Holle"
                },
                {
                    "first": "Ziad",
                    "initial": "Z.",
                    "last": "Zeinoun"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Bauchau"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Verstraeten"
                }
            ],
            "doi": "10.1002/pds.3226",
            "firstpage": "603",
            "issn": "10538569",
            "lastpage": "610",
            "pmid": "22383219",
            "pub_year": 2012,
            "title": "Using time-to-onset for detecting safety signals in spontaneous reports of adverse events following immunization: A proof of concept study",
            "volume": "21"
        },
        "b0090": null,
        "b0095": {
            "authors": [
                {
                    "first": "Fernanda",
                    "initial": "F.",
                    "last": "Tavares Da Silva"
                },
                {
                    "first": "Filip",
                    "initial": "F.",
                    "last": "De Keyser"
                },
                {
                    "first": "Paul Henri",
                    "initial": "P.H.",
                    "last": "Lambert"
                },
                {
                    "first": "William H.",
                    "initial": "W.H.",
                    "last": "Robinson"
                },
                {
                    "first": "Ren\u00e9",
                    "initial": "R.",
                    "last": "Westhovens"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Sindic"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.01.042",
            "firstpage": "1870",
            "issn": "0264410X",
            "lastpage": "1876",
            "pmid": "23391600",
            "pub_year": 2013,
            "title": "Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines",
            "volume": "31"
        },
        "b0100": null,
        "b0105": {
            "authors": [
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Herv\u00e9"
                },
                {
                    "first": "B\u00e9atrice",
                    "initial": "B.",
                    "last": "Laup\u00e8ze"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Del Giudice"
                },
                {
                    "first": "Arnaud M.",
                    "initial": "A.M.",
                    "last": "Didierlaurent"
                },
                {
                    "first": "Fernanda Tavares",
                    "initial": "F.T.",
                    "last": "Da Silva"
                }
            ],
            "doi": "10.1038/s41541-019-0132-6",
            "issn": "20590105",
            "pub_year": 2019,
            "title": "The how\u2019s and what\u2019s of vaccine reactogenicity",
            "volume": "4"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Olivia",
                    "initial": "O.",
                    "last": "Mahaux"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Bauchau"
                },
                {
                    "first": "Lionel",
                    "initial": "L.",
                    "last": "Van Holle"
                }
            ],
            "doi": "10.1002/pds.3918",
            "firstpage": "215",
            "issn": "10538569",
            "lastpage": "222",
            "pmid": "26602179",
            "pub_year": 2016,
            "title": "Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines",
            "volume": "25"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Black"
                },
                {
                    "first": "Juhani",
                    "initial": "J.",
                    "last": "Eskola"
                },
                {
                    "first": "Claire Anne",
                    "initial": "C.A.",
                    "last": "Siegrist"
                },
                {
                    "first": "Neal",
                    "initial": "N.",
                    "last": "Halsey"
                },
                {
                    "first": "Noni",
                    "initial": "N.",
                    "last": "MacDonald"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Law"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                },
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "Andrews"
                },
                {
                    "first": "Julia",
                    "initial": "J.",
                    "last": "Stowe"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Salmon"
                },
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Vannice"
                },
                {
                    "first": "Hector S.",
                    "initial": "H.S.",
                    "last": "Izurieta"
                },
                {
                    "first": "Aysha",
                    "initial": "A.",
                    "last": "Akhtar"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Gold"
                },
                {
                    "first": "Gabriel",
                    "initial": "G.",
                    "last": "Oselka"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Zuber"
                },
                {
                    "first": "Dina",
                    "initial": "D.",
                    "last": "Pfeifer"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Vellozzi"
                }
            ],
            "doi": "10.1016/S0140-6736(09)61877-8",
            "firstpage": "2115",
            "issn": "01406736",
            "lastpage": "2122",
            "pmid": "19880172",
            "pub_year": 2009,
            "title": "Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines",
            "volume": "374"
        },
        "b0120": null,
        "b0125": {
            "authors": [
                {
                    "first": "P. D.",
                    "initial": "P.D.",
                    "last": "Frenzen"
                }
            ],
            "doi": "10.1159/000109501",
            "firstpage": "83",
            "issn": "02515350",
            "lastpage": "88",
            "pmid": "17925599",
            "pub_year": 2007,
            "title": "Hospital admissions for Guillain-Barr\u00e9 syndrome in the United States, 1993-2004",
            "volume": "29"
        },
        "b0130": {
            "authors": [
                {
                    "first": "L. J.",
                    "initial": "L.J.",
                    "last": "Hauck"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "White"
                },
                {
                    "first": "T. E.",
                    "initial": "T.E.",
                    "last": "Feasby"
                },
                {
                    "first": "D. W.",
                    "initial": "D.W.",
                    "last": "Zochodne"
                },
                {
                    "first": "L. W.",
                    "initial": "L.W.",
                    "last": "Svenson"
                },
                {
                    "first": "Michael D.",
                    "initial": "M.D.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1136/jnnp.2007.118810",
            "firstpage": "318",
            "issn": "00223050",
            "lastpage": "320",
            "pmid": "17595235",
            "pub_year": 2008,
            "title": "Incidence of Guillain-Barr\u00e9 syndrome in Alberta, Canada: An administrative data study",
            "volume": "79"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Sabrina",
                    "initial": "S.",
                    "last": "Hense"
                },
                {
                    "first": "Tania",
                    "initial": "T.",
                    "last": "Schink"
                },
                {
                    "first": "Stefan H.",
                    "initial": "S.H.",
                    "last": "Kreisel"
                },
                {
                    "first": "Lydie",
                    "initial": "L.",
                    "last": "Marcelon"
                },
                {
                    "first": "Fran\u00e7ois",
                    "initial": "F.",
                    "last": "Simondon"
                },
                {
                    "first": "Maike",
                    "initial": "M.",
                    "last": "Tahden"
                },
                {
                    "first": "Edeltraut",
                    "initial": "E.",
                    "last": "Garbe"
                }
            ],
            "doi": "10.1159/000369344",
            "firstpage": "244",
            "issn": "02515350",
            "lastpage": "252",
            "pmid": "25531827",
            "pub_year": 2014,
            "title": "Estimation of background incidence rates of guillain-barr\u00e9 syndrome in Germany-A retrospective cohort study with electronic healthcare data",
            "volume": "43"
        },
        "b0140": null,
        "b0145": null,
        "b0150": {
            "authors": [
                {
                    "first": "James J.",
                    "initial": "J.J.",
                    "last": "Sejvar"
                },
                {
                    "first": "Katrin S.",
                    "initial": "K.S.",
                    "last": "Kohl"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Gidudu"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Amato"
                },
                {
                    "first": "Nandini",
                    "initial": "N.",
                    "last": "Bakshi"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "Baxter"
                },
                {
                    "first": "Dale R.",
                    "initial": "D.R.",
                    "last": "Burwen"
                },
                {
                    "first": "David R.",
                    "initial": "D.R.",
                    "last": "Cornblath"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Cleerbout"
                },
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Heininger"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Hughes"
                },
                {
                    "first": "Najwa",
                    "initial": "N.",
                    "last": "Khuri-Bulos"
                },
                {
                    "first": "Rudolf",
                    "initial": "R.",
                    "last": "Korinthenberg"
                },
                {
                    "first": "Barbara J.",
                    "initial": "B.J.",
                    "last": "Law"
                },
                {
                    "first": "Ursula",
                    "initial": "U.",
                    "last": "Munro"
                },
                {
                    "first": "Helena C.",
                    "initial": "H.C.",
                    "last": "Maltezou"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Nell"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Oleske"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Sparks"
                },
                {
                    "first": "Priscilla",
                    "initial": "P.",
                    "last": "Velentgas"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Vermeer"
                },
                {
                    "first": "Max",
                    "initial": "M.",
                    "last": "Wiznitzer"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Blum"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Heath"
                },
                {
                    "first": "Hector",
                    "initial": "H.",
                    "last": "Izurieta"
                },
                {
                    "first": "Brigitte Keller",
                    "initial": "B.K.",
                    "last": "Stanislawski"
                },
                {
                    "first": "Katrin Kohl",
                    "initial": "K.K.",
                    "last": "Odile"
                },
                {
                    "first": "Leroy Adam",
                    "initial": "L.A.",
                    "last": "Rudiger"
                },
                {
                    "first": "Adderson",
                    "initial": "A.",
                    "last": "Elisabeth"
                },
                {
                    "first": "Aguilar",
                    "initial": "A.",
                    "last": "Maria"
                },
                {
                    "first": "Aldrovandi",
                    "initial": "A.",
                    "last": "Grace"
                },
                {
                    "first": "Allen",
                    "initial": "A.",
                    "last": "Mary"
                },
                {
                    "first": "Bachtiar Novilia",
                    "initial": "B.N.",
                    "last": "Sjafri"
                },
                {
                    "first": "Barami A.A.",
                    "initial": "B.A.A.",
                    "last": "Salim"
                },
                {
                    "first": "Baxter",
                    "initial": "B.",
                    "last": "Roger"
                },
                {
                    "first": "Bettinger",
                    "initial": "B.",
                    "last": "Julie"
                },
                {
                    "first": "Bilynsky",
                    "initial": "B.",
                    "last": "Roman"
                },
                {
                    "first": "Blum",
                    "initial": "B.",
                    "last": "Michael"
                },
                {
                    "first": "Bonhoeffer",
                    "initial": "B.",
                    "last": "Jan"
                },
                {
                    "first": "Brady",
                    "initial": "B.",
                    "last": "Michael"
                },
                {
                    "first": "Buettcher",
                    "initial": "B.",
                    "last": "Michael"
                },
                {
                    "first": "Buttery",
                    "initial": "B.",
                    "last": "Jim"
                },
                {
                    "first": "Cane",
                    "initial": "C.",
                    "last": "Alejandro"
                },
                {
                    "first": "Chang",
                    "initial": "C.",
                    "last": "Soju"
                },
                {
                    "first": "Chatterjee",
                    "initial": "C.",
                    "last": "Arani"
                },
                {
                    "first": "Chawla",
                    "initial": "C.",
                    "last": "Krishan"
                },
                {
                    "first": "Cherian",
                    "initial": "C.",
                    "last": "Thomas"
                },
                {
                    "first": "Cleerbout",
                    "initial": "C.",
                    "last": "Jan"
                },
                {
                    "first": "Close",
                    "initial": "C.",
                    "last": "Philippe"
                },
                {
                    "first": "Condit",
                    "initial": "C.",
                    "last": "Richard"
                },
                {
                    "first": "Cornblath",
                    "initial": "C.",
                    "last": "David"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Couch Robert"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Da Costa"
                },
                {
                    "first": "Davis",
                    "initial": "D.",
                    "last": "Larry"
                },
                {
                    "first": "Martins Reinaldo",
                    "initial": "M.R.",
                    "last": "De Menezes"
                },
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "De Vries"
                },
                {
                    "first": "Deotti Sandra",
                    "initial": "D.S.",
                    "last": "Maria"
                },
                {
                    "first": "Dimitrijevic",
                    "initial": "D.",
                    "last": "Dragana"
                },
                {
                    "first": "Dong",
                    "initial": "D.",
                    "last": "Duo"
                },
                {
                    "first": "Evengard",
                    "initial": "E.",
                    "last": "Birgitta"
                },
                {
                    "first": "Falup Pecurariu",
                    "initial": "F.P.",
                    "last": "Cristian"
                },
                {
                    "first": "Fernandopulle",
                    "initial": "F.",
                    "last": "Rohini"
                },
                {
                    "first": "Ferreira",
                    "initial": "F.",
                    "last": "Germano"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Fisher Margaret"
                },
                {
                    "first": "Galama",
                    "initial": "G.",
                    "last": "Jochem"
                },
                {
                    "first": "Gallegos",
                    "initial": "G.",
                    "last": "Karl"
                },
                {
                    "first": "Gershman",
                    "initial": "G.",
                    "last": "Mark"
                },
                {
                    "first": "Gibbs",
                    "initial": "G.",
                    "last": "Neville"
                },
                {
                    "first": "Gidudu",
                    "initial": "G.",
                    "last": "Jane"
                },
                {
                    "first": "Gurwith",
                    "initial": "G.",
                    "last": "Marc"
                },
                {
                    "first": "Halsey",
                    "initial": "H.",
                    "last": "Neal"
                },
                {
                    "first": "Hanlon",
                    "initial": "H.",
                    "last": "Erin"
                },
                {
                    "first": "Hitchcock",
                    "initial": "H.",
                    "last": "William"
                },
                {
                    "first": "Hossain",
                    "initial": "H.",
                    "last": "Shah"
                },
                {
                    "first": "Wan Ting",
                    "initial": "W.T.",
                    "last": "Huang"
                },
                {
                    "first": "Hunter",
                    "initial": "H.",
                    "last": "Deborah"
                },
                {
                    "first": "Isaacs",
                    "initial": "I.",
                    "last": "David"
                },
                {
                    "first": "Jacobson",
                    "initial": "J.",
                    "last": "Robert"
                },
                {
                    "first": "Johann Liang",
                    "initial": "J.L.",
                    "last": "Rosemary"
                },
                {
                    "first": "Jones",
                    "initial": "J.",
                    "last": "Barbara"
                },
                {
                    "first": "Jovancevic",
                    "initial": "J.",
                    "last": "Milivoj"
                },
                {
                    "first": "Kaisar Mahfuzul",
                    "initial": "K.M.",
                    "last": "Islam"
                },
                {
                    "first": "Kang",
                    "initial": "K.",
                    "last": "Gagandeep"
                },
                {
                    "first": "Klug",
                    "initial": "K.",
                    "last": "Bettina"
                },
                {
                    "first": "Korinthenberg",
                    "initial": "K.",
                    "last": "Rudolf"
                },
                {
                    "first": "Kulcsar",
                    "initial": "K.",
                    "last": "Andrea"
                },
                {
                    "first": "Lee",
                    "initial": "L.",
                    "last": "Grace"
                },
                {
                    "first": "Lievano",
                    "initial": "L.",
                    "last": "Fabio"
                },
                {
                    "first": "Noni",
                    "initial": "N.",
                    "last": "MacDonald"
                },
                {
                    "first": "Mahmood",
                    "initial": "M.",
                    "last": "Asif"
                },
                {
                    "first": "Maltezou",
                    "initial": "M.",
                    "last": "Helena"
                },
                {
                    "first": "Martin Martin",
                    "initial": "M.M.",
                    "last": "Susana"
                },
                {
                    "first": "McIntosh G.",
                    "initial": "M.G.",
                    "last": "David"
                },
                {
                    "first": "Mentzer",
                    "initial": "M.",
                    "last": "Dirk"
                },
                {
                    "first": "Meredith",
                    "initial": "M.",
                    "last": "Stefanie"
                },
                {
                    "first": "Meszner",
                    "initial": "M.",
                    "last": "Zsofia"
                },
                {
                    "first": "Milstien",
                    "initial": "M.",
                    "last": "Julie"
                },
                {
                    "first": "Minor",
                    "initial": "M.",
                    "last": "Mary"
                },
                {
                    "first": "Modlin",
                    "initial": "M.",
                    "last": "John"
                },
                {
                    "first": "Montgomery",
                    "initial": "M.",
                    "last": "Jay"
                },
                {
                    "first": "Morse",
                    "initial": "M.",
                    "last": "Ann"
                },
                {
                    "first": "Munro",
                    "initial": "M.",
                    "last": "Ursula"
                },
                {
                    "first": "Nalin",
                    "initial": "N.",
                    "last": "David"
                },
                {
                    "first": "Nell",
                    "initial": "N.",
                    "last": "Patricia"
                },
                {
                    "first": "Nimmannitya",
                    "initial": "N.",
                    "last": "Suchitra"
                },
                {
                    "first": "Nisslein",
                    "initial": "N.",
                    "last": "Thomas"
                },
                {
                    "first": "Nokleby",
                    "initial": "N.",
                    "last": "Hanne"
                },
                {
                    "first": "Nwosu",
                    "initial": "N.",
                    "last": "Kenneth"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Oleske James"
                },
                {
                    "first": "Patnaik",
                    "initial": "P.",
                    "last": "Badri"
                },
                {
                    "first": "Pinheiro",
                    "initial": "P.",
                    "last": "Luis"
                },
                {
                    "first": "Pourmalek",
                    "initial": "P.",
                    "last": "Farshad"
                },
                {
                    "first": "Ramasamy",
                    "initial": "R.",
                    "last": "Ranjan"
                },
                {
                    "first": "Rump",
                    "initial": "R.",
                    "last": "Eva-Beate"
                },
                {
                    "first": "Samson",
                    "initial": "S.",
                    "last": "Heather"
                },
                {
                    "first": "Santos",
                    "initial": "S.",
                    "last": "Eliane"
                },
                {
                    "first": "Schuller",
                    "initial": "S.",
                    "last": "Elisabeth"
                },
                {
                    "first": "Schultze",
                    "initial": "S.",
                    "last": "Viola"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Sidhu Maninder"
                },
                {
                    "first": "Sillan",
                    "initial": "S.",
                    "last": "Francoise"
                },
                {
                    "first": "Sliman",
                    "initial": "S.",
                    "last": "Joseph"
                },
                {
                    "first": "Soh Bee Leng",
                    "initial": "S.B.L.",
                    "last": "Sally"
                },
                {
                    "first": "Sparks",
                    "initial": "S.",
                    "last": "Robert"
                },
                {
                    "first": "Sprenger",
                    "initial": "S.",
                    "last": "Ralf"
                },
                {
                    "first": "Steele",
                    "initial": "S.",
                    "last": "Russell"
                },
                {
                    "first": "Stoller",
                    "initial": "S.",
                    "last": "Rudolf"
                },
                {
                    "first": "Storsaeter",
                    "initial": "S.",
                    "last": "Jann"
                },
                {
                    "first": "Suznjevic",
                    "initial": "S.",
                    "last": "Vladimir"
                },
                {
                    "first": "Tebaa",
                    "initial": "T.",
                    "last": "Amina"
                },
                {
                    "first": "Tridente",
                    "initial": "T.",
                    "last": "Giuseppe"
                },
                {
                    "first": "Trimis",
                    "initial": "T.",
                    "last": "Georgios"
                },
                {
                    "first": "Uhnoo",
                    "initial": "U.",
                    "last": "Ingrid"
                },
                {
                    "first": "Kristy",
                    "initial": "K.",
                    "last": "Van Dinther"
                },
                {
                    "first": "Varricchio",
                    "initial": "V.",
                    "last": "Frederick"
                },
                {
                    "first": "Ventura",
                    "initial": "V.",
                    "last": "Rafael"
                },
                {
                    "first": "Vilella",
                    "initial": "V.",
                    "last": "Anna"
                },
                {
                    "first": "Warden",
                    "initial": "W.",
                    "last": "Beverly"
                },
                {
                    "first": "Weston",
                    "initial": "W.",
                    "last": "William"
                },
                {
                    "first": "Wimalaratne",
                    "initial": "W.",
                    "last": "Omala"
                },
                {
                    "first": "Wong",
                    "initial": "W.",
                    "last": "Virginia"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": "Chun-Nei"
                },
                {
                    "first": "Zajdowicz",
                    "initial": "Z.",
                    "last": "Thad"
                },
                {
                    "first": "Zaman",
                    "initial": "Z.",
                    "last": "Khalequz"
                },
                {
                    "first": "Zanoni",
                    "initial": "Z.",
                    "last": "Giovanna"
                },
                {
                    "first": "Zielinski",
                    "initial": "Z.",
                    "last": "Andrzej"
                },
                {
                    "first": "Zuber",
                    "initial": "Z.",
                    "last": "Patrick"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2010.06.003",
            "firstpage": "599",
            "issn": "0264410X",
            "lastpage": "612",
            "pmid": "20600491",
            "pub_year": 2011,
            "title": "Guillain-Barr\u00e9 syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data",
            "volume": "29"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Alexander D.",
                    "initial": "A.D.",
                    "last": "Langmuir"
                }
            ],
            "doi": "10.1177/014107687907200908",
            "firstpage": "660",
            "issn": "01410768",
            "lastpage": "669",
            "pmid": "552571",
            "pub_year": 1979,
            "title": "Guillain-Barr\u00e9 syndrome: The swine influenza virus vaccine incident in the United States of America, 1976\u201377: Preliminary communication",
            "volume": "72"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Lawrence B.",
                    "initial": "L.B.",
                    "last": "Schonberger"
                },
                {
                    "first": "Dennis J.",
                    "initial": "D.J.",
                    "last": "Bregman"
                },
                {
                    "first": "John Z.",
                    "initial": "J.Z.",
                    "last": "Sullivan-bolyai"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Keenlyside"
                },
                {
                    "first": "Donald W.",
                    "initial": "D.W.",
                    "last": "Ziegler"
                },
                {
                    "first": "Henry F.",
                    "initial": "H.F.",
                    "last": "Retailliau"
                },
                {
                    "first": "Donald L.",
                    "initial": "D.L.",
                    "last": "Eddins"
                },
                {
                    "first": "John A.",
                    "initial": "J.A.",
                    "last": "Bryan"
                }
            ],
            "firstpage": "105",
            "issn": "00029262",
            "lastpage": "123",
            "pmid": "463869",
            "pub_year": 1979,
            "title": "Guillain-barre syndrome following vaccination in the national influenza immunization program, United States, 1976-1977",
            "volume": "110"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Rath"
                },
                {
                    "first": "Jane F.",
                    "initial": "J.F.",
                    "last": "Gidudu"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Anyoti"
                },
                {
                    "first": "Brigid",
                    "initial": "B.",
                    "last": "Bollweg"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Caubel"
                },
                {
                    "first": "Yeoung Hwang",
                    "initial": "Y.H.",
                    "last": "Chen"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Cornblath"
                },
                {
                    "first": "Rohini",
                    "initial": "R.",
                    "last": "Fernandopulle"
                },
                {
                    "first": "Louis",
                    "initial": "L.",
                    "last": "Fries"
                },
                {
                    "first": "Jochem",
                    "initial": "J.",
                    "last": "Galama"
                },
                {
                    "first": "Neville",
                    "initial": "N.",
                    "last": "Gibbs"
                },
                {
                    "first": "Gualtiero",
                    "initial": "G.",
                    "last": "Grilli"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Grogan"
                },
                {
                    "first": "Katharina",
                    "initial": "K.",
                    "last": "Hartmann"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Heininger"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Hudson"
                },
                {
                    "first": "Hector s.",
                    "initial": "H.s.",
                    "last": "Izurieta"
                },
                {
                    "first": "Indira",
                    "initial": "I.",
                    "last": "Jevaji"
                },
                {
                    "first": "Wiltshire M.",
                    "initial": "W.M.",
                    "last": "Johnson"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Jones"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Keller-Stanislawski"
                },
                {
                    "first": "Jerome",
                    "initial": "J.",
                    "last": "Klein"
                },
                {
                    "first": "Katrin",
                    "initial": "K.",
                    "last": "Kohl"
                },
                {
                    "first": "Panagiotis",
                    "initial": "P.",
                    "last": "Kokotis"
                },
                {
                    "first": "Yulin",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Linder"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Oleske"
                },
                {
                    "first": "Georgina",
                    "initial": "G.",
                    "last": "Richard"
                },
                {
                    "first": "Tarek",
                    "initial": "T.",
                    "last": "Shafshak"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Vajdy"
                },
                {
                    "first": "Virginia",
                    "initial": "V.",
                    "last": "Wong"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Sejvar"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2016.05.023",
            "firstpage": "1972",
            "issn": "0264410X",
            "lastpage": "1983",
            "pmid": "27235092",
            "pub_year": 2017,
            "title": "Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data",
            "volume": "35"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Jens U.",
                    "initial": "J.U.",
                    "last": "R\u00fcggeberg"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Gold"
                },
                {
                    "first": "Jos\u00e9 Maria",
                    "initial": "J.M.",
                    "last": "Bayas"
                },
                {
                    "first": "Michael D.",
                    "initial": "M.D.",
                    "last": "Blum"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Bonhoeffer"
                },
                {
                    "first": "Sheila",
                    "initial": "S.",
                    "last": "Friedlander"
                },
                {
                    "first": "Glacus",
                    "initial": "G.",
                    "last": "de Souza Brito"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Heininger"
                },
                {
                    "first": "Babatunde",
                    "initial": "B.",
                    "last": "Imoukhuede"
                },
                {
                    "first": "Ali",
                    "initial": "A.",
                    "last": "Khamesipour"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Erlewyn-Lajeunesse"
                },
                {
                    "first": "Susana",
                    "initial": "S.",
                    "last": "Martin"
                },
                {
                    "first": "Mika",
                    "initial": "M.",
                    "last": "M\u00e4kel\u00e4"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Nell"
                },
                {
                    "first": "Vitali",
                    "initial": "V.",
                    "last": "Pool"
                },
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "Simpson"
                }
            ],
            "doi": "10.1016/j.vaccine.2007.02.064",
            "firstpage": "5675",
            "issn": "0264410X",
            "lastpage": "5684",
            "pmid": "17448577",
            "pub_year": 2007,
            "title": "Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data",
            "volume": "25"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Neal A.",
                    "initial": "N.A.",
                    "last": "Halsey"
                }
            ],
            "doi": "10.1053/spid.2002.125864",
            "firstpage": "205",
            "issn": "10451870",
            "lastpage": "214",
            "pmid": "12199617",
            "pub_year": 2002,
            "title": "The science of evaluation of adverse events associated with vaccination",
            "volume": "13"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Stephen A.",
                    "initial": "S.A.",
                    "last": "Goldman"
                }
            ],
            "doi": "10.1016/S0149-2918(98)80007-6",
            "firstpage": "C40",
            "issn": "01492918",
            "lastpage": "C44",
            "pub_year": 1998,
            "title": "Limitations and strengths of spontaneous reports data",
            "volume": "20"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Katrijn",
                    "initial": "K.",
                    "last": "Grupping"
                },
                {
                    "first": "Sean",
                    "initial": "S.",
                    "last": "Matthews"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Butuk"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Chen"
                },
                {
                    "first": "Mohamed El",
                    "initial": "M.E.",
                    "last": "Idrissi"
                },
                {
                    "first": "Laurence A.",
                    "initial": "L.A.",
                    "last": "Fissette"
                },
                {
                    "first": "Charles",
                    "initial": "C.",
                    "last": "Fogarty"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Hartley"
                },
                {
                    "first": "Nicola P.",
                    "initial": "N.P.",
                    "last": "Klein"
                },
                {
                    "first": "Max",
                    "initial": "M.",
                    "last": "Nevarez"
                },
                {
                    "first": "Kari",
                    "initial": "K.",
                    "last": "Uusinarkaus"
                },
                {
                    "first": "Lidia",
                    "initial": "L.",
                    "last": "Oostvogels"
                },
                {
                    "first": "Desmond",
                    "initial": "D.",
                    "last": "Curran"
                }
            ],
            "doi": "10.1093/gerona/gly218",
            "firstpage": "1217",
            "issn": "10795006",
            "lastpage": "1224",
            "pmid": "30256905",
            "pub_year": 2019,
            "title": "The impact of reactogenicity after the first dose of recombinant zoster vaccine on the physical functioning and quality of life of older adults: An open-label, phase III trial",
            "volume": "74"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Arnaud M.",
                    "initial": "A.M.",
                    "last": "Didierlaurent"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Collignon"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Bourguignon"
                },
                {
                    "first": "Sandrine",
                    "initial": "S.",
                    "last": "Wouters"
                },
                {
                    "first": "Kaat",
                    "initial": "K.",
                    "last": "Fierens"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Fochesato"
                },
                {
                    "first": "Najoua",
                    "initial": "N.",
                    "last": "Dendouga"
                },
                {
                    "first": "Christelle",
                    "initial": "C.",
                    "last": "Langlet"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Malissen"
                },
                {
                    "first": "Bart N.",
                    "initial": "B.N.",
                    "last": "Lambrecht"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Gar\u00e7on"
                },
                {
                    "first": "Marcelle",
                    "initial": "M.",
                    "last": "Van Mechelen"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Morel"
                }
            ],
            "doi": "10.4049/jimmunol.1400948",
            "firstpage": "1920",
            "issn": "00221767",
            "lastpage": "1930",
            "pmid": "25024381",
            "pub_year": 2014,
            "title": "Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells",
            "volume": "193"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Meghan A.",
                    "initial": "M.A.",
                    "last": "Baker"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Nguyen"
                },
                {
                    "first": "David V.",
                    "initial": "D.V.",
                    "last": "Cole"
                },
                {
                    "first": "Grace M.",
                    "initial": "G.M.",
                    "last": "Lee"
                },
                {
                    "first": "Tracy A.",
                    "initial": "T.A.",
                    "last": "Lieu"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.04.088",
            "firstpage": "K98",
            "issn": "0264410X",
            "lastpage": "K112",
            "pmid": "24331080",
            "pub_year": 2013,
            "title": "Post-licensure rapid immunization safety monitoring program (PRISM) data characterization",
            "volume": "31"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Maria Donata",
                    "initial": "M.D.",
                    "last": "Benedetti"
                },
                {
                    "first": "Maura",
                    "initial": "M.",
                    "last": "Pugliatti"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Dalessandro"
                },
                {
                    "first": "Ettore",
                    "initial": "E.",
                    "last": "Beghi"
                },
                {
                    "first": "Adriano",
                    "initial": "A.",
                    "last": "Chi\u00f2"
                },
                {
                    "first": "Giancarlo",
                    "initial": "G.",
                    "last": "Logroscino"
                },
                {
                    "first": "Graziella",
                    "initial": "G.",
                    "last": "Filippini"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Galeotti"
                },
                {
                    "first": "Marco",
                    "initial": "M.",
                    "last": "Massari"
                },
                {
                    "first": "Carmela",
                    "initial": "C.",
                    "last": "Santuccio"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Raschetti"
                }
            ],
            "doi": "10.1159/000438752",
            "firstpage": "90",
            "issn": "02515350",
            "lastpage": "99",
            "pmid": "26329724",
            "pub_year": 2015,
            "title": "A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study",
            "volume": "45"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Delannoy"
                },
                {
                    "first": "J\u00e9r\u00e9mie",
                    "initial": "J.",
                    "last": "Rudant"
                },
                {
                    "first": "Christophe",
                    "initial": "C.",
                    "last": "Chaignot"
                },
                {
                    "first": "Francis",
                    "initial": "F.",
                    "last": "Bolgert"
                },
                {
                    "first": "Yann",
                    "initial": "Y.",
                    "last": "Mikaeloff"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Weill"
                }
            ],
            "doi": "10.1111/jns.12202",
            "firstpage": "51",
            "issn": "10859489",
            "lastpage": "58",
            "pmid": "27991707",
            "pub_year": 2017,
            "title": "Guillain-Barr\u00e9 syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008\u20132013)",
            "volume": "22"
        },
        "b0210": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Skufca"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Ollgren"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Ruokokoski"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Lyytik\u00e4inen"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Nohynek"
                }
            ],
            "doi": "10.1016/j.pvr.2017.03.001",
            "firstpage": "91",
            "issn": "24058521",
            "lastpage": "96",
            "pmid": "28720463",
            "pub_year": 2017,
            "title": "Incidence rates of Guillain Barr\u00e9 (GBS), chronic fatigue/systemic exertion intolerance disease (CFS/SEID) and postural orthostatic tachycardia syndrome (POTS) prior to introduction of human papilloma virus (HPV) vaccination among adolescent girls in Finland, 2002\u20132012",
            "volume": "3"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Nicoline A.T.",
                    "initial": "N.A.T.",
                    "last": "Van Der Maas"
                },
                {
                    "first": "Merlijn A.",
                    "initial": "M.A.",
                    "last": "Kramer"
                },
                {
                    "first": "Bart C.",
                    "initial": "B.C.",
                    "last": "Jacobs"
                },
                {
                    "first": "Eva M.",
                    "initial": "E.M.",
                    "last": "Van Soest"
                },
                {
                    "first": "Jeanne P.",
                    "initial": "J.P.",
                    "last": "Dieleman"
                },
                {
                    "first": "Jeanet M.",
                    "initial": "J.M.",
                    "last": "Kemmeren"
                },
                {
                    "first": "Hester E.",
                    "initial": "H.E.",
                    "last": "De Melker"
                },
                {
                    "first": "Miriam C.J.M.",
                    "initial": "M.C.J.M.",
                    "last": "Sturkenboom"
                }
            ],
            "doi": "10.1111/j.1529-8027.2011.00356.x",
            "firstpage": "243",
            "issn": "10859489",
            "lastpage": "249",
            "pmid": "22003939",
            "pub_year": 2011,
            "title": "Guillain-Barr\u00e9 syndrome: Background incidence rates in the Netherlands",
            "volume": "16"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Elisabeth M.",
                    "initial": "E.M.",
                    "last": "Hesse"
                },
                {
                    "first": "Tom T.",
                    "initial": "T.T.",
                    "last": "Shimabukuro"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Su"
                },
                {
                    "first": "Beth F.",
                    "initial": "B.F.",
                    "last": "Hibbs"
                },
                {
                    "first": "Kathleen L.",
                    "initial": "K.L.",
                    "last": "Dooling"
                },
                {
                    "first": "Ravi",
                    "initial": "R.",
                    "last": "Goud"
                },
                {
                    "first": "Paige",
                    "initial": "P.",
                    "last": "Lewis"
                },
                {
                    "first": "Carmen S.",
                    "initial": "C.S.",
                    "last": "Ng"
                },
                {
                    "first": "Maria V.",
                    "initial": "M.V.",
                    "last": "Cano"
                }
            ],
            "doi": "10.15585/MMWR.MM6804A4",
            "firstpage": "91",
            "issn": "01492195",
            "lastpage": "94",
            "pmid": "30703077",
            "pub_year": 2019,
            "title": "Postlicensure safety surveillance of recombinant Zoster vaccine (Shingrix) \u2014 United States, october 2017\u2013june 2018",
            "volume": "68"
        },
        "b0225": null,
        "b0230": null,
        "b0235": {
            "authors": [
                {
                    "first": "Beth F.",
                    "initial": "B.F.",
                    "last": "Hibbs"
                },
                {
                    "first": "Pedro L.",
                    "initial": "P.L.",
                    "last": "Moro"
                },
                {
                    "first": "Paige",
                    "initial": "P.",
                    "last": "Lewis"
                },
                {
                    "first": "Elaine R.",
                    "initial": "E.R.",
                    "last": "Miller"
                },
                {
                    "first": "Tom T.",
                    "initial": "T.T.",
                    "last": "Shimabukuro"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.05.006",
            "firstpage": "3171",
            "issn": "0264410X",
            "lastpage": "3178",
            "pmid": "25980429",
            "pub_year": 2015,
            "title": "Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013",
            "volume": "33"
        },
        "b0240": {
            "authors": [
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Su"
                },
                {
                    "first": "Elaine R.",
                    "initial": "E.R.",
                    "last": "Miller"
                },
                {
                    "first": "Jonathan",
                    "initial": "J.",
                    "last": "Duffy"
                },
                {
                    "first": "Bethany M.",
                    "initial": "B.M.",
                    "last": "Baer"
                },
                {
                    "first": "Maria V.",
                    "initial": "M.V.",
                    "last": "Cano"
                }
            ],
            "doi": "10.15585/mmwr.mm6506a4",
            "firstpage": "161",
            "issn": "01492195",
            "lastpage": "162",
            "pmid": "26890604",
            "pub_year": 2016,
            "title": "Administration error involving a meningococcal conjugate vaccine \u2014 United states, march 1, 2010\u2013september 22, 2015",
            "volume": "65"
        },
        "b0245": null,
        "b0250": {
            "authors": [
                {
                    "first": "Tom T.",
                    "initial": "T.T.",
                    "last": "Shimabukuro"
                },
                {
                    "first": "Elaine R.",
                    "initial": "E.R.",
                    "last": "Miller"
                },
                {
                    "first": "Raymond A.",
                    "initial": "R.A.",
                    "last": "Strikas"
                },
                {
                    "first": "Beth F.",
                    "initial": "B.F.",
                    "last": "Hibbs"
                },
                {
                    "first": "Kathleen",
                    "initial": "K.",
                    "last": "Dooling"
                },
                {
                    "first": "Ravi",
                    "initial": "R.",
                    "last": "Goud"
                },
                {
                    "first": "Maria V.",
                    "initial": "M.V.",
                    "last": "Cano"
                }
            ],
            "firstpage": "585",
            "issn": "01492195",
            "lastpage": "586",
            "pmid": "29795075",
            "pub_year": 2018,
            "title": "Vaccine administration errors involving recombinant Zoster vaccine \u2014 United States, 2017\u20132018",
            "volume": "67"
        },
        "b0255": null,
        "b0260": {
            "authors": [
                {
                    "first": "Kathleen L.",
                    "initial": "K.L.",
                    "last": "Dooling"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Guo"
                },
                {
                    "first": "Manisha",
                    "initial": "M.",
                    "last": "Patel"
                },
                {
                    "first": "Grace M.",
                    "initial": "G.M.",
                    "last": "Lee"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Moore"
                },
                {
                    "first": "Edward A.",
                    "initial": "E.A.",
                    "last": "Belongia"
                },
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Harpaz"
                }
            ],
            "doi": "10.15585/mmwr.mm6703a5",
            "firstpage": "103",
            "issn": "01492195",
            "lastpage": "108",
            "pmid": "29370152",
            "pub_year": 2018,
            "title": "Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines",
            "volume": "67"
        },
        "b0265": null
    },
    "body_text": [
        {
            "endOffset": 35129,
            "parents": [],
            "secId": "s0010",
            "sentence": "O/E analyses were performed for the selected events to determine whether the observed number of a reported AE corresponded to the number of events expected to occur within a predefined risk period, under the null hypothesis of no association between vaccination and the event.",
            "startOffset": 34853,
            "title": "Methods"
        },
        {
            "endOffset": 56822,
            "parents": [],
            "secId": "s0060",
            "sentence": "It is worth noting that RZV demand exceeded supply during the observation time and reports of inappropriate/incomplete course of administration may have been due to the supply shortages that have occurred for RZV during the same period; however, in most cases the reason for these errors was not provided.",
            "startOffset": 56517,
            "title": "Discussion"
        },
        {
            "endOffset": 56516,
            "parents": [],
            "secId": "s0060",
            "sentence": "Limitations of these reports include the generally inconsistent data quality and completeness, that many errors might go completely unnoticed or not reported and that some might not be true vaccination errors (e.g. delays in immunization due to supply shortages classified as \u201cInappropriate Schedule\u201d errors).",
            "startOffset": 56207,
            "title": "Discussion"
        },
        {
            "endOffset": 26310,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 26309,
                    "startOffset": 26306
                }
            },
            "secId": "s0005",
            "sentence": "Incidence rates of HZ in the general population range from three to five per 1,000 person-years in various countries, and are consistently increasing with age [2].",
            "startOffset": 26147,
            "title": "Introduction"
        },
        {
            "endOffset": 48209,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The outcome was unknown or not reported in 177 reports.",
            "startOffset": 48154,
            "title": "Herpes zoster, including herpes zoster-like rash and complications"
        },
        {
            "endOffset": 28326,
            "parents": [],
            "secId": "s0005",
            "sentence": "Continued collection and evaluation of safety data following the introduction of a new vaccine to the general population is pivotal for the early detection and investigation of signals temporally-associated with vaccination.",
            "startOffset": 28102,
            "title": "Introduction"
        },
        {
            "endOffset": 45736,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Of all spontaneous reports, 179 reports concerned individuals who had reported a pre-existing pIMD in the medical history and who also reported an AE after vaccination with RZV.",
            "startOffset": 45559,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 55477,
            "parents": [],
            "refoffsets": {
                "b0245": {
                    "endOffset": 55476,
                    "startOffset": 55472
                }
            },
            "secId": "s0060",
            "sentence": "These errors may have reflected the lack of familiarity of HCPs with the RZV specificities during the early phase post-licensure and the 10 years of practice with the live attenuated virus zoster vaccine (ZVL; Zostavax, Merck) in the US, which is reconstituted prior to subcutaneous administration by injecting the provided diluent into a vial containing the lyophilized component [49].",
            "startOffset": 55091,
            "title": "Discussion"
        },
        {
            "endOffset": 57367,
            "parents": [],
            "secId": "s0060",
            "sentence": "Reports of HZ, HZ-like rash or HZ complications accounted for 5.5% of the overall number of reports, with most occurring in persons not fully vaccinated.",
            "startOffset": 57214,
            "title": "Discussion"
        },
        {
            "endOffset": 49988,
            "parents": [],
            "secId": "s0060",
            "sentence": "One of the strengths of the passive safety surveillance is the rapid collection of data following real-world use of the product in the general population, including individuals with concurrent illnesses treated with concomitant medications or high-risk individuals for whom pre-licensure clinical trial data is typically limited, as well as rare or less frequent events not observed in pre-licensure clinical trials.",
            "startOffset": 49572,
            "title": "Discussion"
        },
        {
            "endOffset": 58574,
            "parents": [],
            "secId": "s0070",
            "sentence": "Zostavax is a trademark of Merck Sharp & Dohme Corp.",
            "startOffset": 58522,
            "title": "Trademark statement"
        },
        {
            "endOffset": 45375,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Seventy-three (69.5%) reports were received from the US, 30 (28.6%) from Canada and two (1.9%) from Germany.",
            "startOffset": 45267,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 32339,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 32338,
                    "startOffset": 32334
                }
            },
            "secId": "s0010",
            "sentence": "GSK adopted the safety signal definition of the Council for International Organizations of Medical Sciences-VIII: \u201cinformation that arises from one or multiple sources (including observations and experiments), which suggests a new potentially causal association, or a new aspect of a known association, between an intervention and an event or set of related events, either adverse or beneficial, that is judged to be of sufficient likelihood to justify verificatory action\u201d [18].",
            "startOffset": 31860,
            "title": "Methods"
        },
        {
            "endOffset": 54600,
            "parents": [],
            "secId": "s0060",
            "sentence": "Vaccination errors are events that might reflect incorrect use of the product and the monitoring of these spontaneous reports offers a mechanism to introduce corrective strategies.",
            "startOffset": 54420,
            "title": "Discussion"
        },
        {
            "endOffset": 31623,
            "parents": [],
            "secId": "s0010",
            "sentence": "TTO was calculated from the date of vaccination with any dose of RZV (Day 0) to AE start date, for reports containing available information.",
            "startOffset": 31483,
            "title": "Methods"
        },
        {
            "endOffset": 27461,
            "parents": [],
            "secId": "s0005",
            "sentence": "RZV consists of a recombinant subunit VZV glycoprotein E (gE) combined with an Adjuvant System, AS01B.",
            "startOffset": 27359,
            "title": "Introduction"
        },
        {
            "endOffset": 45415,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "The age ranged between 50 and 95 years.",
            "startOffset": 45376,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 28515,
            "parents": [],
            "secId": "s0005",
            "sentence": "This article summarizes the post-marketing safety surveillance data involving RZV, reported worldwide to GSK from spontaneous sources during the period October 13, 2017 \u2013 February 10, 2019.",
            "startOffset": 28326,
            "title": "Introduction"
        },
        {
            "endOffset": 46782,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "For Bell\u2019s palsy, the O/E analyses of reports, assessed as Brighton Collaboration level 1\u20134 of diagnostic certainty and considering a risk period of seven or 30 days following vaccination, were found to be below the expected number considering several scenarios of underreporting and background incidence rates and for both risk periods (Fig. 5B and C, Appendices 6 and 7).",
            "startOffset": 46409,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 50402,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 50401,
                    "startOffset": 50397
                }
            },
            "secId": "s0060",
            "sentence": "Limitations of post-marketing passive surveillance that relies on spontaneous reports include reporting bias (which can be due to country-specific reporting environment, influences of media, or length of time the product has been on the market), underreporting, missing information such as lack of denominator data, misclassification or incorrect information, and the absence of an adequate comparator group [36].",
            "startOffset": 49989,
            "title": "Discussion"
        },
        {
            "endOffset": 57610,
            "parents": [],
            "secId": "s0060",
            "sentence": "Therefore one may assume that most have been due to reactivations of wild-type VZV infections, anticipated to occur in the target population, althought data from spontaneous reporting systems cannot be used to draw conclusions in this regard.",
            "startOffset": 57368,
            "title": "Discussion"
        },
        {
            "endOffset": 31204,
            "parents": [],
            "secId": "s0010",
            "sentence": "The comparator was restricted to populations \u226550 years of age (the target population) and from countries in which RZV is distributed.",
            "startOffset": 31071,
            "title": "Methods"
        },
        {
            "endOffset": 45190,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "The reported events were distributed over a range of body systems and disease categories (Table 5).",
            "startOffset": 45091,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 48153,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Most suspected or confirmed vaccination failure reports were from Canada (68.5%) and from a non-medically confirmed source, which could explain the lack of information.",
            "startOffset": 47985,
            "title": "Herpes zoster, including herpes zoster-like rash and complications"
        },
        {
            "endOffset": 30260,
            "parents": [],
            "secId": "s0010",
            "sentence": "The review and analyses of spontaneous report data extracted from the GSK safety database (Oracle Argus) and other internal data sources was performed via an in-house Spotfire web application, the Signal Mining and Management (SMM) tool.",
            "startOffset": 30023,
            "title": "Methods"
        },
        {
            "endOffset": 53259,
            "parents": [],
            "secId": "s0060",
            "sentence": "This was based on a small number of reports (four) after administration of approximately 106,000 doses of RZV.",
            "startOffset": 53149,
            "title": "Discussion"
        },
        {
            "endOffset": 33604,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 33603,
                    "startOffset": 33599
                }
            },
            "secId": "s0010",
            "sentence": "The reactogenicity is a subset of AEs (that occur soon after immunization and are a physical manifestation of the inflammatory response to vaccination), and includes injection-site reactions (pain, redness, swelling) as well as systemic symptoms (fever, myalgia, fatigue, chills headache, malaise or gastrointestinal symptoms such as nausea, vomiting and diarrhea) [21].",
            "startOffset": 33234,
            "title": "Methods"
        },
        {
            "endOffset": 51506,
            "parents": [],
            "secId": "s0060",
            "sentence": "These reactions associated to the vaccine reactogenicity occurring in close temporal association to vaccination are expected as common, generally low grade in intensity, self-limiting and of short duration, and generally do not require medical intervention.",
            "startOffset": 51249,
            "title": "Discussion"
        },
        {
            "endOffset": 34362,
            "parents": [],
            "secId": "s0010",
            "sentence": "A \u201csuspected vaccination failure\u201d was defined as the occurrence of HZ clinical symptoms suggestive of VZV infection occurring 30 days or later after full vaccination schedule with RZV.",
            "startOffset": 34178,
            "title": "Methods"
        },
        {
            "endOffset": 49088,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "There was no evidence for disproportionate reporting of these events.",
            "startOffset": 49019,
            "title": "Other events of medical interest"
        },
        {
            "endOffset": 40225,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Of the 15,638 reports, 805 (5.1%) described symptoms potentially linked to severe reactogenicity (see search strategy in Appendix 1).",
            "startOffset": 40092,
            "title": "Common adverse events"
        },
        {
            "endOffset": 54724,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 54723,
                    "startOffset": 54719
                }
            },
            "secId": "s0060",
            "sentence": "Prior experiences with other vaccines indicate that vaccination errors are highest in the period shortly after launch [47].",
            "startOffset": 54601,
            "title": "Discussion"
        },
        {
            "endOffset": 41413,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Most of these described more than one error in a single report.",
            "startOffset": 41350,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 42626,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Among the reports of incorrect route of administration, RZV was most commonly given subcutaneously instead of intramuscularly.",
            "startOffset": 42500,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 42957,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "In addition, among the 463 product storage errors that occurred, 103 (22.2%) were intercepted and the vaccine was not administered, and in the remaining 360 (77.8%) the vaccine was administered.",
            "startOffset": 42763,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 48643,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0170": {
                    "endOffset": 48561,
                    "startOffset": 48557
                }
            },
            "secId": "s0055",
            "sentence": "Of these, two were assessed as possibly vaccine-related and Brighton Collaboration for anaphylaxis CD level 2 [34], corresponding to a reporting rate of 0.02 reports per 100,000 doses distributed.",
            "startOffset": 48447,
            "title": "Other events of medical interest"
        },
        {
            "endOffset": 29329,
            "parents": [],
            "secId": "s0010",
            "sentence": "Attempts for obtaining necessary follow-up information are made to obtain supplementary clinical information needed for the scientific evaluation of the cases.",
            "startOffset": 29170,
            "title": "Methods"
        },
        {
            "endOffset": 41768,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "No other unusual pattern of AEs was observed.",
            "startOffset": 41723,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 57213,
            "parents": [],
            "refoffsets": {
                "b0265": {
                    "endOffset": 57030,
                    "startOffset": 57026
                }
            },
            "secId": "s0060",
            "sentence": "It is worth noting that in March 2018, the RZV Facebook page in Canada [53] turned on the capability to comment and following this, an increase in these AEs reported by patients/consumers having limited clinical data for diagnosis ascertainment was observed.",
            "startOffset": 56955,
            "title": "Discussion"
        },
        {
            "endOffset": 38025,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "The most commonly co-administered vaccines were seasonal influenza, diphtheria-tetanus-pertussis (reduced antigen) and pneumococcal vaccines.",
            "startOffset": 37884,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 36159,
            "parents": [],
            "secId": "s0010",
            "sentence": "For GBS and Bell\u2019s palsy, AE onset was used to assign cases to the respective risk windows.",
            "startOffset": 36068,
            "title": "Methods"
        },
        {
            "endOffset": 40393,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Most of the 805 reports were non-serious (81.4%), from individuals 60\u201369 years old (39.3%) and reported in females (74.2% of reports for which the sex was documented).",
            "startOffset": 40226,
            "title": "Common adverse events"
        },
        {
            "endOffset": 55646,
            "parents": [],
            "refoffsets": {
                "b0250": {
                    "endOffset": 55645,
                    "startOffset": 55641
                }
            },
            "secId": "s0060",
            "sentence": "A similar conclusion was previously drawn from early VAERS data on vaccine administration errors during the first four months following licensure of RZV in the US [50].",
            "startOffset": 55478,
            "title": "Discussion"
        },
        {
            "endOffset": 55090,
            "parents": [],
            "secId": "s0060",
            "sentence": "Errors related to inappropriate/incorrect route of administration and storage conditions were also frequently reported in this post-marketing surveillance.",
            "startOffset": 54935,
            "title": "Discussion"
        },
        {
            "endOffset": 58274,
            "parents": [],
            "secId": "s0065",
            "sentence": "Despite the the known limitations of post-marketing passive surveillance that relies on spontaneous AE reports, these data provide important safety information allowing ongoing evaluation of reported AEs following RZV immunization in the general population \u226550 years of age.",
            "startOffset": 58000,
            "title": "Conclusions"
        },
        {
            "endOffset": 47771,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Of the 865 case reports of HZ or HZ-related complications, 178 met the criteria for a suspected or confirmed vaccination failure (see search strategy in Appendix 1 and definitions in Section 2).",
            "startOffset": 47577,
            "title": "Herpes zoster, including herpes zoster-like rash and complications"
        },
        {
            "endOffset": 52892,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 52891,
                    "startOffset": 52887
                }
            },
            "secId": "s0060",
            "sentence": "The US Centers for Disease Control and Prevention conducted descriptive analyses of reports to the VAERS involving RZV for the period October 20, 2017 to June 30, 2018 and concluded that no AEs reported for RZV were disproportionate to AE reporting patterns observed for other vaccines in the VAERS database [44].",
            "startOffset": 52579,
            "title": "Discussion"
        },
        {
            "endOffset": 25969,
            "parents": [],
            "secId": "s0005",
            "sentence": "Primary VZV infection results in varicella (chickenpox), after which VZV becomes latent in neurons of the dorsal root and cranial nerve ganglia.",
            "startOffset": 25825,
            "title": "Introduction"
        },
        {
            "endOffset": 27067,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 27066,
                    "startOffset": 27059
                },
                "b0055": {
                    "endOffset": 27066,
                    "startOffset": 27059
                },
                "b0060": {
                    "endOffset": 27066,
                    "startOffset": 27059
                }
            },
            "secId": "s0005",
            "sentence": "Pre-licensure data showed that the adjuvanted recombinant zoster vaccine (RZV; Shingrix, GSK) is highly efficacious in preventing HZ in individuals \u226550 years of age and supported a favourable benefit-risk profile of RZV in all age-groups studied [10\u201312].",
            "startOffset": 26813,
            "title": "Introduction"
        },
        {
            "endOffset": 27961,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 27960,
                    "startOffset": 27956
                }
            },
            "secId": "s0005",
            "sentence": "RZV is administered as a two-dose intramuscular series (two to six months apart) [13].",
            "startOffset": 27875,
            "title": "Introduction"
        },
        {
            "endOffset": 37268,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "In total, 14,897 (95.3%) reports were non-serious and the remaining 741 (4.7%) reports fulfilled the ICH \u201cserious\u201d criteria, which included nine reports of death.",
            "startOffset": 37106,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 44821,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "The O/E analysis was performed for all-cause mortality considering a risk period of seven days following vaccination and was found to be below the expected range, possibly indicating a very high underreporting of this outcome (Fig. 3, Appendix 5).",
            "startOffset": 44574,
            "title": "Fatal reports"
        },
        {
            "endOffset": 56076,
            "parents": [],
            "refoffsets": {
                "b0255": {
                    "endOffset": 56075,
                    "startOffset": 56068
                },
                "b0260": {
                    "endOffset": 56075,
                    "startOffset": 56068
                }
            },
            "secId": "s0060",
            "sentence": "Several measures \u2013 such as distribution of educational materials on proper product handling, dosing and administration, highlighting the vaccine presentation and reconstitution step in local prescribing information leaflets and engagement with the Centers for Disease Control and Prevention to highlight the differences between preparation of ZVL and RZV \u2013 were proposed in the ACIP recommendations for use of HZ vaccine [51,52].",
            "startOffset": 55647,
            "title": "Discussion"
        },
        {
            "endOffset": 39114,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Overall, a similar reporting pattern was observed by age (data not shown).",
            "startOffset": 39040,
            "title": "Common adverse events"
        },
        {
            "endOffset": 58447,
            "parents": [],
            "secId": "s0065",
            "sentence": "The present review, based on post-marketing data, is reassuring and reinforces the clinically acceptable safety profile of RZV, previously established in clinical settings.",
            "startOffset": 58275,
            "title": "Conclusions"
        },
        {
            "endOffset": 31482,
            "parents": [],
            "secId": "s0010",
            "sentence": "A quantitative signal of unexpected temporal relationship for a RZV\u2013AE pair is generated when its TTO distribution within 60 days post-vaccination is significantly different from the same AE reported with comparators or from the reported TTO distribution of other RZV\u2013AE pairs.",
            "startOffset": 31205,
            "title": "Methods"
        },
        {
            "endOffset": 54934,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 54933,
                    "startOffset": 54929
                }
            },
            "secId": "s0060",
            "sentence": "Vaccination errors occurring during the RZV surveillance were mainly related to reconstitution and administration of only one component, as previously observed for other vaccines requiring reconstitution [48].",
            "startOffset": 54725,
            "title": "Discussion"
        },
        {
            "endOffset": 56206,
            "parents": [],
            "secId": "s0060",
            "sentence": "Because the error rates seem to be declining with time in the US, these measures were considered sufficient to address the issue.",
            "startOffset": 56077,
            "title": "Discussion"
        },
        {
            "endOffset": 56954,
            "parents": [],
            "secId": "s0060",
            "sentence": "The frequency of suspected or confirmed vaccination failure was very low and the majority (68.5%) of these reports were from Canada.",
            "startOffset": 56822,
            "title": "Discussion"
        },
        {
            "endOffset": 37009,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Table 1 displays characteristics of the spontaneous reports after RZV vaccination.",
            "startOffset": 36927,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 33771,
            "parents": [],
            "secId": "s0010",
            "sentence": "We defined severe reactogenicity as symptoms causing quality-of-life impairment, disability or preventing normal daily activities (see search strategy in Appendix 1).",
            "startOffset": 33605,
            "title": "Methods"
        },
        {
            "endOffset": 36067,
            "parents": [],
            "secId": "s0010",
            "sentence": "Reports with an unknown TTO were included in the O/E analyses.",
            "startOffset": 36005,
            "title": "Methods"
        },
        {
            "endOffset": 42762,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Among the 463 reports of storage errors, the most common error (N = 215; 46.4%) was storage in the freezer instead of the refrigerator.",
            "startOffset": 42627,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 41533,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "An overview of the vaccination error reports by MedDRA high level terms and preferred terms is presented in Appendix 4.",
            "startOffset": 41414,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 29169,
            "parents": [],
            "secId": "s0010",
            "sentence": "These communications (referred to as \u201cspontaneous reports\u201d) are either submitted to GSK directly and voluntarily from individual reporters (who may be reporting for themselves or others) via local reception/call centres or are collected by GSK from the scientific literature or the interactive digital media.",
            "startOffset": 28861,
            "title": "Methods"
        },
        {
            "endOffset": 45267,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "There was no evidence for disproportionate reporting of any of these events.",
            "startOffset": 45191,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 46101,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "O/E analyses were performed for GBS and Bell\u2019s palsy (the two most frequently reported pIMDs).",
            "startOffset": 46007,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 53977,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 53976,
                    "startOffset": 53972
                }
            },
            "secId": "s0060",
            "sentence": "The reported pIMDs may represent temporally-associated events, occurring as background incidence in the general population [44].",
            "startOffset": 53849,
            "title": "Discussion"
        },
        {
            "endOffset": 50770,
            "parents": [],
            "secId": "s0060",
            "sentence": "These passive reporting systems are most suited at detecting events that may have a short latency period; however, they likely capture events that are commonly occurring in the general population and not necessarily associated with vaccine exposure.",
            "startOffset": 50521,
            "title": "Discussion"
        },
        {
            "endOffset": 45916,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Seventeen of these patients reportedly had apparent flares of the pre-existing disease after vaccination, most common of which were rheumatoid arthritis or polymyalgia rheumatica.",
            "startOffset": 45737,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 36233,
            "parents": [],
            "secId": "s0010",
            "sentence": "Cases with unknown AE onset were conservatively included in the analyses.",
            "startOffset": 36160,
            "title": "Methods"
        },
        {
            "endOffset": 34504,
            "parents": [],
            "secId": "s0010",
            "sentence": "Observed-to-expected (O/E) analyses were performed for mortality (all-cause) and the two most frequently reported pIMDs, GBS and Bell\u2019s palsy.",
            "startOffset": 34362,
            "title": "Methods"
        },
        {
            "endOffset": 35346,
            "parents": [],
            "secId": "s0010",
            "sentence": "For all-cause mortality, all reports of death temporally-associated with vaccination were reviewed medically and an O/E analysis was performed considering a risk period of seven days (Day 0\u2013Day 6) after immunization.",
            "startOffset": 35130,
            "title": "Methods"
        },
        {
            "endOffset": 49571,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 49570,
                    "startOffset": 49566
                }
            },
            "secId": "s0060",
            "sentence": "These AEs, while temporally-associated with the product\u2019s use, may not necessarily be causally associated with it [35].",
            "startOffset": 49452,
            "title": "Discussion"
        },
        {
            "endOffset": 29676,
            "parents": [],
            "secId": "s0010",
            "sentence": "One spontaneous report can contain more than one AE, reported by the same individual.",
            "startOffset": 29591,
            "title": "Methods"
        },
        {
            "endOffset": 37688,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "HCPs submitted 11,760 reports (75.2%), of which 6,482 (55.1%) were by pharmacists.",
            "startOffset": 37606,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 25824,
            "parents": [],
            "secId": "s0005",
            "sentence": "Herpes zoster (HZ), otherwise known as shingles, is typically a painful and debilitating disease that is caused by the reactivation of latent varicella-zoster virus (VZV).",
            "startOffset": 25653,
            "title": "Introduction"
        },
        {
            "endOffset": 37407,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Among the 6,641 reports where the age was documented, 62.1% were from individuals 50\u201369 years old and 35.1% from individuals \u226570 years old.",
            "startOffset": 37268,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 39453,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Of these, 2,849 (61.4%) described injection site reactions, with pain being the most commonly reported (Appendix 3).",
            "startOffset": 39337,
            "title": "Common adverse events"
        },
        {
            "endOffset": 53677,
            "parents": [],
            "refoffsets": {
                "b0230": {
                    "endOffset": 53676,
                    "startOffset": 53672
                }
            },
            "secId": "s0060",
            "sentence": "An update was presented at the ACIP meeting on June 26, 2019 and the Committee noted that the preliminary data were insufficient to conclude that a safety problem exists for GBS, but further evaluation and continued monitoring were warranted [46].",
            "startOffset": 53430,
            "title": "Discussion"
        },
        {
            "endOffset": 43225,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "The most commonly reported symptoms in serious reports were HZ (N = 207; 27.6%), pyrexia (N = 72; 9.6%), pain in extremity (N = 69; 9.2%), and pain (N = 63; 8.4%) (Table 4).",
            "startOffset": 43052,
            "title": "Serious reports"
        },
        {
            "endOffset": 47407,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The 50 HZ-related complications were: HZ ophthalmicus (N = 25; 0.3 reports per 100,000 doses distributed), post-herpetic neuralgia (N = 21; 0.2 reports per 100,000 doses distributed), two reports of HZ with neurological infection for which limited information was available for assessment, and two reports of HZ oticus (one of which lacked sufficient information for assessment and for the other the clinical picture was not compatible with Ramsay Hunt syndrome).",
            "startOffset": 46944,
            "title": "Herpes zoster, including herpes zoster-like rash and complications"
        },
        {
            "endOffset": 40793,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "When described, these events occurred within the first few days after vaccination and generally lasted 3\u20134 days, although in rare occasions, symptoms persisted for one week or more.",
            "startOffset": 40612,
            "title": "Common adverse events"
        },
        {
            "endOffset": 50979,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 50978,
                    "startOffset": 50968
                },
                "b0055": {
                    "endOffset": 50978,
                    "startOffset": 50968
                },
                "b0060": {
                    "endOffset": 50978,
                    "startOffset": 50968
                },
                "b0185": {
                    "endOffset": 50978,
                    "startOffset": 50968
                }
            },
            "secId": "s0060",
            "sentence": "The review of the initial post-marketing safety surveillance of RZV is reassuring and appears consistent with safety findings reported in pre-licensure clinical trials, including the pivotal trials [10\u201312,37].",
            "startOffset": 50770,
            "title": "Discussion"
        },
        {
            "endOffset": 40092,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Overall, the reporting frequency of reactogenicity symptoms was similar in the different age strata, with a tendency to report more injection site reactions in individuals \u226570 years of age, while individuals 50\u201369 years of age more commonly reported systemic reactogenicity symptoms (data not shown).",
            "startOffset": 39792,
            "title": "Common adverse events"
        },
        {
            "endOffset": 49018,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Reports of other events of medical interest following RZV vaccination, such as ocular events that might be due to vasculitis or inflammation, seizures/convulsions, acute myocardial ischemia, stroke/cerebrovascular accident, or supraventricular tachyarrhythmias (see search strategy in Appendix 1; data not shown), were infrequent and accounted for <0.1% of the total reports.",
            "startOffset": 48643,
            "title": "Other events of medical interest"
        },
        {
            "endOffset": 57999,
            "parents": [],
            "secId": "s0065",
            "sentence": "The safety profile of the vaccine will continue to be monitored in ongoing clinical trials and post-marketing passive and active safety surveillance.",
            "startOffset": 57850,
            "title": "Conclusions"
        },
        {
            "endOffset": 26465,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 26464,
                    "startOffset": 26461
                }
            },
            "secId": "s0005",
            "sentence": "HZ complications occur in nearly 25% of persons with HZ and become more frequent with age [4].",
            "startOffset": 26371,
            "title": "Introduction"
        },
        {
            "endOffset": 43363,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "When described, median age was 84 years (range = 62\u2013100 years).",
            "startOffset": 43300,
            "title": "Fatal reports"
        },
        {
            "endOffset": 41349,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Of all spontaneous reports, there were 3,579 (22.9%) reports of vaccination errors following RZV.",
            "startOffset": 41252,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 52216,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, the conclusions that can be drawn from the O/E analyses are hindered by limitations inherent to the spontaneous safety data reporting.",
            "startOffset": 52073,
            "title": "Discussion"
        },
        {
            "endOffset": 31859,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 31797,
                    "startOffset": 31793
                }
            },
            "secId": "s0010",
            "sentence": "The TTO signal detection used a quantitative signal threshold of 1% (p-value < 0.01) on the p-values of both Kolmogorov\u2013Smirnov tests (across products and across events [17]) and there was no restriction to the background (comparator).",
            "startOffset": 31624,
            "title": "Methods"
        },
        {
            "endOffset": 42275,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Among the errors during vaccine preparation or reconstitution, the most common were due to the administration of the AS01B adjuvant system only or mixing the RZV lyophilized antigen with a diluent rather than the supplied adjuvant system.",
            "startOffset": 42037,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 51796,
            "parents": [],
            "secId": "s0060",
            "sentence": "As anticipated, the observed quantitative signals of the RZV\u2013AE pairs were either for reactions already recognized in the RZV local prescribing information leaflets (including those linked to the vaccine reactogenicity and hypersensitivity reactions) or for certain vaccination error types.",
            "startOffset": 51506,
            "title": "Discussion"
        },
        {
            "endOffset": 45090,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "This corresponded to a reporting rate of 1.1 reports per 100,000 doses distributed.",
            "startOffset": 45007,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 52579,
            "parents": [],
            "secId": "s0060",
            "sentence": "Other potential limitations are the uncertainties related to the true risk period (i.e. exact time period of increased vaccine\u2010associated risk is generally unknown) and the relevance of the background incidence rates for the exposed population (calculated from a targeted population unexposed to RZV), and the number of doses actually administered by age strata.",
            "startOffset": 52217,
            "title": "Discussion"
        },
        {
            "endOffset": 57776,
            "parents": [],
            "secId": "s0060",
            "sentence": "The occurrence of other AEs of interest in the target population, as well as serious AEs, were rare after RZV immunization, and have not suggested any safety concern.",
            "startOffset": 57610,
            "title": "Discussion"
        },
        {
            "endOffset": 40611,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Of these, the most commonly reported AEs were: decreased mobility of the injected arm (1.8 reports per 100,000 doses distributed) and extensive swelling of the injected arm (1.4 reports per 100,000 doses distributed).",
            "startOffset": 40394,
            "title": "Common adverse events"
        },
        {
            "endOffset": 50520,
            "parents": [],
            "secId": "s0060",
            "sentence": "The clinical information provided by the reporter is often limited and may preclude the interpretation of the report.",
            "startOffset": 50403,
            "title": "Discussion"
        },
        {
            "endOffset": 41252,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "In Germany and Canada, the proportion of vaccination errors remained relatively low (around 20%) and stable (Fig. 2).",
            "startOffset": 41135,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 26662,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 26661,
                    "startOffset": 26654
                },
                "b0015": {
                    "endOffset": 26585,
                    "startOffset": 26578
                },
                "b0025": {
                    "endOffset": 26585,
                    "startOffset": 26578
                },
                "b0030": {
                    "endOffset": 26661,
                    "startOffset": 26654
                },
                "b0035": {
                    "endOffset": 26661,
                    "startOffset": 26654
                },
                "b0040": {
                    "endOffset": 26661,
                    "startOffset": 26654
                }
            },
            "secId": "s0005",
            "sentence": "The most common HZ complication is post-herpetic neuralgia, which develops in around 10\u201330% of patients with HZ [2,3,5], followed by HZ ophthalmicus, which occurs in 10\u201320% of HZ patients [2,6\u20138].",
            "startOffset": 26466,
            "title": "Introduction"
        },
        {
            "endOffset": 39039,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "During the analytical period, the most frequently reported symptoms following RZV vaccination were consistent with the vaccine reactogenicity (Table 2, Fig. 1).",
            "startOffset": 38879,
            "title": "Common adverse events"
        },
        {
            "endOffset": 40970,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "In January 2018, a safety signal was identified due to the high percentage of reports (52% of all reports received worldwide) describing vaccination errors.",
            "startOffset": 40814,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 54419,
            "parents": [],
            "secId": "s0060",
            "sentence": "The observed reporting rates of vaccination errors were not unexpected.",
            "startOffset": 54348,
            "title": "Discussion"
        },
        {
            "endOffset": 43632,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "The interval from vaccination to onset of symptoms was described in three reports (6.5 h, 61 and 61 days after unspecified dose of RZV) and the interval from vaccination to death was described in four reports (same day, three days, 61 and 61 days after a dose of RZV).",
            "startOffset": 43364,
            "title": "Fatal reports"
        },
        {
            "endOffset": 38560,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Quantitative signals of the RZV\u2013AE pairs during the analytical period were flagged for common AEs directly or indirectly associated to the vaccine reactogenicity (e.g. injection site reactions, pyrexia, chills, headache, fatigue, etc.), for other adverse reactions listed in RZV local prescribing information leaflets (e.g. urticaria, rash), as well as for some AEs featuring vaccination errors (e.g. incorrect dose or incorrect route of product administration) or those associated to the disease targeted by RZV, i.e. HZ (Appendix 2).",
            "startOffset": 38025,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 41134,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "In the US, the percentage of vaccination errors decreased from 70% in January 2018 to 25% in June 2018 and has since remained stable (ranging between 18% and 30%).",
            "startOffset": 40971,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 48446,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The evaluation using the SMQ anaphylaxis (see narrow search in Appendix 1) retrieved a total of 10 reports of anaphylaxis (MedDRA PTs: Anaphylactic reaction, Anaphylactic shock, Anaphylactoid reaction).",
            "startOffset": 48244,
            "title": "Other events of medical interest"
        },
        {
            "endOffset": 37105,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "A total of 12,770 (81.7%) reports originated from the US, where most RZV doses were distributed.",
            "startOffset": 37009,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 39251,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "More specifically, 4,639 reports described symptoms potentially linked to the vaccine reactogenicity (see search strategy in Appendix 1).",
            "startOffset": 39114,
            "title": "Common adverse events"
        },
        {
            "endOffset": 47577,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Laboratory confirmation of VZV infection (i.e. VZV-positive polymerase chain reaction, culture, immunohistochemical staining, or other tests) was typically not reported.",
            "startOffset": 47408,
            "title": "Herpes zoster, including herpes zoster-like rash and complications"
        },
        {
            "endOffset": 35498,
            "parents": [],
            "secId": "s0010",
            "sentence": "Cases with unknown time to death were conservatively included in the analysis.",
            "startOffset": 35420,
            "title": "Methods"
        },
        {
            "endOffset": 33066,
            "parents": [],
            "secId": "s0010",
            "sentence": "The groups of AESIs were searched using standardized or customized (in-house) MedDRA (version 21.0) queries (SMQs and GSKMQs, respectively) (Appendix 1).",
            "startOffset": 32913,
            "title": "Methods"
        },
        {
            "endOffset": 26370,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 26369,
                    "startOffset": 26366
                }
            },
            "secId": "s0005",
            "sentence": "Of all HZ episodes, 68% occur in adults aged \u226550 years [3].",
            "startOffset": 26311,
            "title": "Introduction"
        },
        {
            "endOffset": 28860,
            "parents": [],
            "secId": "s0010",
            "sentence": "Spontaneous report data are collated from unsolicited communications describing one or more adverse events (AEs) that occur in patients who were given RZV.",
            "startOffset": 28705,
            "title": "Methods"
        },
        {
            "endOffset": 38855,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "The prescribing information leaflet is a document included in the package of any medication, such as the RZV vaccine, that provides information for medical professionals and patients about the medication and its use, including indication, administration, precautions and potential side effects.",
            "startOffset": 38561,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 26813,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 26755,
                    "startOffset": 26752
                }
            },
            "secId": "s0005",
            "sentence": "Both HZ and its complications have a substantial impact on the patients\u2019 quality-of-life [9], thus reinforcing the need for vaccination to prevent HZ.",
            "startOffset": 26663,
            "title": "Introduction"
        },
        {
            "endOffset": 37512,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "The remaining 2.8% were from individuals <50 years old, with reports of vaccination error predominating.",
            "startOffset": 37408,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 28704,
            "parents": [],
            "secId": "s0010",
            "sentence": "An analysis of spontaneous report data involving RZV vaccination extracted from the GSK safety database was conducted for the analytical period October 13, 2017 \u2013 February 10, 2019.",
            "startOffset": 28523,
            "title": "Methods"
        },
        {
            "endOffset": 29445,
            "parents": [],
            "secId": "s0010",
            "sentence": "The individual reporters can include healthcare professionals (HCPs), regulatory authorities, consumers and others.",
            "startOffset": 29330,
            "title": "Methods"
        },
        {
            "endOffset": 57849,
            "parents": [],
            "secId": "s0065",
            "sentence": "RZV was licensed in several countries more than one year ago.",
            "startOffset": 57788,
            "title": "Conclusions"
        },
        {
            "endOffset": 30023,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 30022,
                    "startOffset": 30018
                }
            },
            "secId": "s0010",
            "sentence": "AEs are classified as serious if meeting the ICH regulatory definition: any untoward medical occurrence that results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring, or is a medically important event [15].",
            "startOffset": 29677,
            "title": "Methods"
        },
        {
            "endOffset": 45559,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "All reports with documented TTO occurred within 60 days post-vaccination (Fig. 4), and more than half occurred within 1 week after vaccination.",
            "startOffset": 45416,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 49279,
            "parents": [],
            "secId": "s0060",
            "sentence": "While pre-licensure clinical trials assess the vaccine\u2019s safety profile, continued monitoring of the vaccine\u2019s real-world safety profile in the post-licensure setting is essential.",
            "startOffset": 49099,
            "title": "Discussion"
        },
        {
            "endOffset": 27556,
            "parents": [],
            "secId": "s0005",
            "sentence": "The truncated gE antigen is provided in a lyophilized form (a white powder) in monodose vials.",
            "startOffset": 27462,
            "title": "Introduction"
        },
        {
            "endOffset": 51248,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 51163,
                    "startOffset": 51159
                },
                "b0190": {
                    "endOffset": 51247,
                    "startOffset": 51243
                }
            },
            "secId": "s0060",
            "sentence": "The majority (95.3%) of the AEs reported were non-serious and generally consistent with the known reactogenicity profile of the vaccine observed in pre-licensure clinical studies [12] and the kinetics of the inflammatory response induced by RZV in animal studies [38].",
            "startOffset": 50980,
            "title": "Discussion"
        },
        {
            "endOffset": 32912,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 32502,
                    "startOffset": 32498
                }
            },
            "secId": "s0010",
            "sentence": "For RZV, AESIs included potential immune-mediated diseases (pIMDs) [19], and other conditions of interest due to imbalances noted between treatment groups in prelicensure clinical trials, or conditions of general interest when assessing vaccine safety in the target population (i.e., anaphylaxis, ocular events that might be due to vasculitis or inflammation, seizures/convulsions, acute myocardial ischemia, stroke/cerebrovascular accident, and supraventricular tachyarrhythmias).",
            "startOffset": 32431,
            "title": "Methods"
        },
        {
            "endOffset": 33234,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 33233,
                    "startOffset": 33229
                }
            },
            "secId": "s0010",
            "sentence": "When available, standardized case definitions (CD) from the Brighton Collaboration were applied during reviews to assess the level of diagnostic certainty of AEs [20].",
            "startOffset": 33067,
            "title": "Methods"
        },
        {
            "endOffset": 28101,
            "parents": [],
            "secId": "s0005",
            "sentence": "Based on sales data, an estimated 9.3 million doses of RZV were distributed up to February 2019, of which around 8.4 million in the US only.",
            "startOffset": 27961,
            "title": "Introduction"
        },
        {
            "endOffset": 37606,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Among the 10,539 reports where the sex was documented, 66.7% were female and 33.3% were male.",
            "startOffset": 37513,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 39663,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Most of these reports were non-serious (95.9%), from individuals 60\u201369 years old (38.9% of reports for which the age was documented) and reported in females (71.3% of reports for which the sex was documented).",
            "startOffset": 39454,
            "title": "Common adverse events"
        },
        {
            "endOffset": 30588,
            "parents": [],
            "secId": "s0010",
            "sentence": "Data from external sources were reviewed separately for signal detection purposes, including spontaneous report data from external public safety databases: the US Vaccine Adverse Event Reporting System (VAERS), the Canada Vigilance Adverse Reaction Online Database, and the European Medicines Agency (EMA) EudraVigilance system.",
            "startOffset": 30260,
            "title": "Methods"
        },
        {
            "endOffset": 42499,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Among the reports of inappropriate/incomplete course of administration, the errors described were: a time interval between doses too long, or too short, or incomplete course of vaccination (i.e. only one dose administered).",
            "startOffset": 42276,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 34672,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 34671,
                    "startOffset": 34667
                }
            },
            "secId": "s0010",
            "sentence": "Background incidence rates were defined by the number of incident reports of a condition or event occurring naturally in the population, expressed in person-time [22].",
            "startOffset": 34505,
            "title": "Methods"
        },
        {
            "endOffset": 53848,
            "parents": [],
            "secId": "s0060",
            "sentence": "Our evaluation of the pIMDs, were overall consistent with CDC and ACIP analyses described above and the reporting patterns observed for other vaccines in the GSK database.",
            "startOffset": 53677,
            "title": "Discussion"
        },
        {
            "endOffset": 30766,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 30765,
                    "startOffset": 30758
                },
                "b0085": {
                    "endOffset": 30765,
                    "startOffset": 30758
                }
            },
            "secId": "s0010",
            "sentence": "In the SMM tool, quantitative signals for RZV\u2013AE pairs were flagged if there was disproportionate reporting or evidence of an unexpected time-to-onset (TTO) distribution [16,17].",
            "startOffset": 30588,
            "title": "Methods"
        },
        {
            "endOffset": 53148,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 53147,
                    "startOffset": 53143
                }
            },
            "secId": "s0060",
            "sentence": "At the US Advisory Committee on Immunization Practices (ACIP) meeting on February 28, 2019, the Committee presented data regarding a \u201cpreliminary statistical signal\u201d for GBS after RZV in a sequential analysis of data from the Vaccine Safety Datalink [45].",
            "startOffset": 52893,
            "title": "Discussion"
        },
        {
            "endOffset": 31070,
            "parents": [],
            "secId": "s0010",
            "sentence": "The chosen method for the disproportionality analysis was the stratified proportional reporting ratio (PRR) with a quantitative signal generated when the lower limit of the 95% confidence interval of the stratified PRR is above the threshold of 2 and when at least 3 RZV spontaneous cases were reported.",
            "startOffset": 30767,
            "title": "Methods"
        },
        {
            "endOffset": 39336,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "This corresponded to a reporting rate of 49.8 reports per 100,000 doses distributed.",
            "startOffset": 39252,
            "title": "Common adverse events"
        },
        {
            "endOffset": 49451,
            "parents": [],
            "secId": "s0060",
            "sentence": "One of the main sources of safety information for newly approved vaccines (as for any medication) is the routine post-marketing surveillance of AEs reported spontaneously.",
            "startOffset": 49280,
            "title": "Discussion"
        },
        {
            "endOffset": 45006,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "A total of 105 reports (from 104 individuals) encompassing 114 pIMDs (see search strategy in Appendix 1) were received during the analytical period.",
            "startOffset": 44858,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 29590,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 29589,
                    "startOffset": 29585
                }
            },
            "secId": "s0010",
            "sentence": "All reported AEs are coded using the International Conference on Harmonisation (ICH) Medical Dictionary for Regulatory Activities (MedDRA) [14].",
            "startOffset": 29446,
            "title": "Methods"
        },
        {
            "endOffset": 37883,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Of all reports, 148 (0.9%) described co-administration with other vaccine(s) on the same calendar day and no unusual pattern of AEs was observed compared with those reported following RZV alone.",
            "startOffset": 37689,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 42036,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Most vaccination errors (N = 1,062; 29.7%) were errors of preparation and reconstitution, followed by inappropriate/incomplete course of administration (N = 956; 26.7%), incorrect route of administration (N = 585; 16.3%), and storage errors (N = 463; 12.9%) (Table 3).",
            "startOffset": 41768,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 27874,
            "parents": [],
            "secId": "s0005",
            "sentence": "AS01B (a liposome-based adjuvant comprising 3-O-desacyl-4\u2032-monophosphoryl lipid A, a Toll-like receptor 4 ligand and QS-21, a saponin extracted from the bark of the Quillaja saponaria Molina tree) is provided in a liquid form in separate monodose vials (0.5 ml/dose) and is used for reconstitution prior to injection.",
            "startOffset": 27557,
            "title": "Introduction"
        },
        {
            "endOffset": 41722,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Of all vaccination error reports, 82.7% were without associated symptoms, 17.3% were associated to symptoms (mostly injection site reactions following subcutaneous route of administration).",
            "startOffset": 41533,
            "title": "Vaccination errors"
        },
        {
            "endOffset": 58521,
            "parents": [],
            "secId": "s0070",
            "sentence": "Shingrix is a trademark of the GSK group of companies.",
            "startOffset": 58467,
            "title": "Trademark statement"
        },
        {
            "endOffset": 27359,
            "parents": [],
            "secId": "s0005",
            "sentence": "RZV received its first marketing authorization for HZ prevention in adults \u226550 years of age in Canada, followed by the United States (US), both in October 2017, and was subsequently licensed in the European Union (March 2018), Japan (April 2018), Australia (July 2018), and China (May 2019).",
            "startOffset": 27068,
            "title": "Introduction"
        },
        {
            "endOffset": 39791,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "When described, vaccine reactogenicity symptoms occurred within the first days after vaccination and generally lasted 3\u20134 days.",
            "startOffset": 39664,
            "title": "Common adverse events"
        },
        {
            "endOffset": 43299,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "A total of nine deaths after receipt of RZV were reported.",
            "startOffset": 43241,
            "title": "Fatal reports"
        },
        {
            "endOffset": 43051,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "A total of 741 (4.7%) reports were serious, including nine reports of death.",
            "startOffset": 42975,
            "title": "Serious reports"
        },
        {
            "endOffset": 44574,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 44354,
                    "startOffset": 44350
                }
            },
            "secId": "s0040",
            "sentence": "Of the remaining four reports, one individual was possibly immunosuppressed with a pre-existing primary membranous nephropathy undergoing treatment with rituximab, and died at an unspecified time after RZV vaccination possibly due to sepsis; two individuals who had cardiac risk factors (including aortic stenosis in one patient and chronic hypertension and diabetes mellitus for the other), died on the same day and three days after RZV vaccination, respectively, and their cause of death was reportedly associated to cardiovascular disease; finally, one individual was diagnosed with GBS, assessed as Brighton Collaboration level 4 [30], at an unspecified time after immunization with the second dose of RZV and an unspecified quadrivalent influenza vaccine, and possibly died due to GBS-associated complications one week after diagnosis of this condition.",
            "startOffset": 43716,
            "title": "Fatal reports"
        },
        {
            "endOffset": 46007,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "All these episodes lacked sufficient clinical information for adequate medical assessment.",
            "startOffset": 45917,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 52072,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 52071,
                    "startOffset": 52055
                },
                "b0125": {
                    "endOffset": 52071,
                    "startOffset": 52055
                },
                "b0130": {
                    "endOffset": 52071,
                    "startOffset": 52055
                },
                "b0135": {
                    "endOffset": 52071,
                    "startOffset": 52055
                },
                "b0195": {
                    "endOffset": 52071,
                    "startOffset": 52055
                },
                "b0200": {
                    "endOffset": 52071,
                    "startOffset": 52055
                },
                "b0205": {
                    "endOffset": 52071,
                    "startOffset": 52055
                },
                "b0210": {
                    "endOffset": 52071,
                    "startOffset": 52055
                },
                "b0215": {
                    "endOffset": 52071,
                    "startOffset": 52055
                }
            },
            "secId": "s0060",
            "sentence": "The O/E analyses performed for mortality (all-cause) and the two most frequently reported pIMDs, GBS and Bell\u2019s palsy, following RZV did not suggest a greater frequency of these outcomes following vaccination compared to the expected range in this population [23,25\u201327,39\u201343].",
            "startOffset": 51796,
            "title": "Discussion"
        },
        {
            "endOffset": 32430,
            "parents": [],
            "secId": "s0010",
            "sentence": "AEs of interest (AESIs) analyzed here do not imply causal association with RZV vaccination.",
            "startOffset": 32339,
            "title": "Methods"
        },
        {
            "endOffset": 36926,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "During the analytical period, 9,323,118 doses of RZV were distributed globally and GSK received 15,638 spontaneous reports of individuals documenting 37,697 total AEs (of which 36,539 non-serious and 1,158 serious AEs) following RZV vaccination.",
            "startOffset": 36681,
            "title": "Overview of spontaneous adverse event reports"
        },
        {
            "endOffset": 34177,
            "parents": [],
            "secId": "s0010",
            "sentence": "A \u201cconfirmed vaccination failure\u201d was defined as the occurrence of HZ clinical symptoms and laboratory confirmation of VZV infection (i.e. VZV-positive polymerase chain reaction, culture, immunohistochemical staining, or other tests that strongly suggest VZV infection and which have been performed in the course of a medical evaluation) occurring 30 days or later after full vaccination schedule with RZV.",
            "startOffset": 33771,
            "title": "Methods"
        },
        {
            "endOffset": 34852,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 34768,
                    "startOffset": 34761
                },
                "b0120": {
                    "endOffset": 34768,
                    "startOffset": 34761
                },
                "b0125": {
                    "endOffset": 34768,
                    "startOffset": 34761
                },
                "b0130": {
                    "endOffset": 34768,
                    "startOffset": 34761
                },
                "b0135": {
                    "endOffset": 34768,
                    "startOffset": 34761
                },
                "b0140": {
                    "endOffset": 34768,
                    "startOffset": 34761
                },
                "b0145": {
                    "endOffset": 34768,
                    "startOffset": 34761
                }
            },
            "secId": "s0010",
            "sentence": "These age and country-stratified background estimates were obtained from the literature [23\u201329], considering populations with similar characteristics to the RZV target population.",
            "startOffset": 34673,
            "title": "Methods"
        },
        {
            "endOffset": 35419,
            "parents": [],
            "secId": "s0010",
            "sentence": "Time to death was used to assign cases to the risk period of seven days.",
            "startOffset": 35347,
            "title": "Methods"
        },
        {
            "endOffset": 46408,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "For GBS, the O/E analyses of reports, assessed as Brighton Collaboration level 1 to 4 of diagnostic certainty and considering a risk period of 42 days following vaccination, were found to be below the expected number considering several scenarios of underreporting and background incidence rates (Fig. 5A).",
            "startOffset": 46102,
            "title": "Potential immune-mediated diseases"
        },
        {
            "endOffset": 47984,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Of these, 176 reports (1.9 reports per 100,000 doses distributed) were considered as \u201csuspected vaccination failure\u201d and two reports (0.02 reports per 100,000 doses distributed) were confirmed vaccination failure.",
            "startOffset": 47771,
            "title": "Herpes zoster, including herpes zoster-like rash and complications"
        },
        {
            "endOffset": 54348,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 54211,
                    "startOffset": 54207
                }
            },
            "secId": "s0060",
            "sentence": "While the time needed for an exposure to initiate an autoimmune/immune-mediated process leading to a clinically observable illness is generally unknown, we consider that an interval of more than 5\u20137 days would possibly be needed [19], therefore the short TTO (\u22647 days) observed for most pIMDs following vaccination argues against a possible association with vaccination.",
            "startOffset": 53978,
            "title": "Discussion"
        },
        {
            "endOffset": 35725,
            "parents": [],
            "refoffsets": {
                "b0150": {
                    "endOffset": 35724,
                    "startOffset": 35717
                },
                "b0155": {
                    "endOffset": 35724,
                    "startOffset": 35717
                },
                "b0160": {
                    "endOffset": 35724,
                    "startOffset": 35717
                }
            },
            "secId": "s0010",
            "sentence": "For GBS, all reports were reviewed based on Brighton Collaboration diagnostic levels [30], and an O/E analysis was performed considering levels 1 to 4 of diagnosis certainty and a risk period of 42 days (Day 0\u2013Day 41) [30\u201332].",
            "startOffset": 35499,
            "title": "Methods"
        },
        {
            "endOffset": 36004,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 35824,
                    "startOffset": 35820
                }
            },
            "secId": "s0010",
            "sentence": "For Bell\u2019s palsy, all reports were reviewed based on Brighton Collaboration diagnostic levels [33] and an O/E analysis was performed considering levels 1 to 4 of diagnosis certainty and a risk period of either seven (Day 0\u2013Day 6) or 30 days (Day 0\u2013Day 29) following vaccination.",
            "startOffset": 35726,
            "title": "Methods"
        },
        {
            "endOffset": 46943,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "A total of 865 spontaneous reports documented 837 HZ events and 50 HZ-related complications.",
            "startOffset": 46851,
            "title": "Herpes zoster, including herpes zoster-like rash and complications"
        },
        {
            "endOffset": 26146,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 26145,
                    "startOffset": 26142
                }
            },
            "secId": "s0005",
            "sentence": "With increasing age, when immunosenescence starts to manifest or when the immune system is impaired, the risk of VZV reactivation, and consequently of developing HZ, rises [1].",
            "startOffset": 25970,
            "title": "Introduction"
        },
        {
            "endOffset": 43715,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Of all reports, five lacked sufficient information for adequate medical assessment.",
            "startOffset": 43632,
            "title": "Fatal reports"
        },
        {
            "endOffset": 58781,
            "parents": [],
            "secId": "s0075",
            "sentence": "Information on GSK\u2019s data sharing commitments and requesting access to anonymized individual participant data and associated documents can be found at www.clinicalstudydatarequest.com.",
            "startOffset": 58597,
            "title": "Data sharing statement"
        },
        {
            "endOffset": 53429,
            "parents": [],
            "secId": "s0060",
            "sentence": "Upon chart review, two cases were determined to be historical, one was a valid case in the risk interval, and one case was valid with a questionable onset risk interval.",
            "startOffset": 53260,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19316007",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "fernanda.tavares@gsk.com",
                "first": "Fernanda",
                "initial": "F.",
                "last": "Tavares-Da-Silva"
            },
            {
                "email": "maribel.x.co@gsk.com",
                "first": "Maribel Miranda",
                "initial": "M.M.",
                "last": "Co"
            },
            {
                "email": "christophe.d.dessart@gsk.com",
                "first": "Christophe",
                "initial": "C.",
                "last": "Dessart"
            },
            {
                "email": "caroline.c.herve@gsk.com",
                "first": "Caroline",
                "initial": "C.",
                "last": "Herv\u00e9"
            },
            {
                "email": "marta.x.lopez-fauqued@gsk.com",
                "first": "Marta",
                "initial": "M.",
                "last": "L\u00f3pez-Fauqued"
            },
            {
                "email": "olivia.x.malhaux@gsk.com",
                "first": "Olivia",
                "initial": "O.",
                "last": "Mahaux"
            },
            {
                "email": "lionel.vanholle@gmail.com",
                "first": "Lionel",
                "initial": "L.",
                "last": "Van Holle"
            },
            {
                "email": "jens-ulrich.x.stegmann@gsk.com",
                "first": "Jens Ulrich",
                "initial": "J.U.",
                "last": "Stegmann"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.11.058",
        "firstpage": "3489",
        "issn": "0264410X",
        "keywords": [
            "AS01",
            "Herpes zoster",
            "Post-marketing safety",
            "Recombinant zoster vaccine"
        ],
        "lastpage": "3500",
        "openaccess": "Full",
        "pub_year": 2020,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine"
    }
}